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ABSTRACT
TEST MODEL OF A HEALTHY LIFESTYLE INTERVENTION PROGRAM
by
JORIE C. ALLEN
University of New Hampshire, December, 2012
The purpose of this study was to evaluate whether a worksite health
promotion (WHP) delivered in a small workplace, improves health risk factors, is
cost-effective, and positively impacts health behaviors.
Comparison (C, n = 31) and Intervention (I, n = 29) groups underwent
health risk assessment and screening at baseline, 12 and 24 months. The I
group attended lifestyle classes at the workplace and reported pedometer step
counts. Data were analyzed using general linear model ANOVA or Chi square
analysis.
At 12 months from baseline, the I group had a decreased LDL cholesterol
(LDL-C) (126.67 ±4.0 mg/dl to 110.86 ± 4.4 mg/dl p = 0.011), and average steps
per day increased (5253 ± 368 steps, 7149 ± 400 steps, p = 0.01). No changes
were noted in waist circumference (WC), or metabolic syndrome (MetS) markers.
In the C group from baseline, WC increased (37.1 ±0.4 in, 38.9 ± 0.4 in, p=
0.001), and MetS markers increased (1.44 ±0.1, 1.88 ± 0.1 markers, p = 0.018)
to a value that was also greater than that in the I group at 12 months (1.29 ± 0.1
markers, p = 0.002). Dietary omega-6/omega-3 fatty acid ratio was found to be

greater than that of the I group (14.49 ±1.8; 10.33 ±2.3, p = 0.03). Costeffectiveness compared favorably to other studies.
At 24 months, LDL-C and Mets markers were not different from the 12 to
24 month values, either within or between groups. WC of the I group (37.3 in)
was significantly less than the C group (38.7 in, p = 0.04). C-reactive protein of
the I group was 44% less than that of the C group (p = 0.027). More of the I
group than the C group participants reported increased physical activity (84.2%
vs. 41.2 % , p = 0.007) and improved diet (63.2% vs. 29.4 %, p = 0.043). Both
groups were highly receptive to a WHP.
This study demonstrated that health risks and health behaviors can
improve following a WHP in a small workplace that is also cost-effective, and
well-accepted by employees.

xi

CHAPTER 1: WORKSITE HEALTH PROMOTION REDUCES HEALTH RISKS

AMONG EMPLOYEES OF UNIVERSITY OF NEW HAMPSHIRE
COOPERATIVE EXTENSION

Introduction
A paradox of life in Westernized society is that in this age of technological
and medical advances, there is an epidemic of lethal chronic disease. Chronic
diseases, that include cardiovascular diseases (CVD), coronary heart disease
(CHD), and type 2 diabetes mellitus (T2DM), are leading causes of death.
Metabolic syndrome (MetS), a clustering of risk factors for all of these conditions
is increasing in prevalence, as well. The data that links modern lifestyle to these
conditions is extensive; however, there is also a large body of evidence
documenting that modification of diet and physical activity can delay onset,
prevent, or even reverse these disorders (1). Based on risk factor identification,
these conditions are predictable; and importantly, they are also preventable (2,
3).
In 2006, cardiovascular disease (CVD) was estimated to affect 37% of the
population. It was the leading cause of death, and ranked highest among all
disease categories in hospital discharges. CVD claims more lives each year than
cancer, chronic lung disease and accidents combined and was estimated to
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generate costs of over $503 billion in 2010. The CVD category of illnesses is
broad and includes (CHD), hypertension and stroke (4).
Additionally in 2006, diabetes affected 23.5 million US adults; cost was
$174 billion and was the seventh-leading cause of death. However, it is widely
believed that diabetes as a cause of death is underreported, since it is a major
factor in CHD, stroke and hypertension. CVD is the leading cause of death in
people with T2DM; adults with diabetes have heart disease death rates about
two to four times higher than adults without diabetes (5).
The metabolic syndrome (MetS) is an additional cardiometabolic risk
condition that is defined by markers of dyslipidemia, hypertension, hyperglycemia
and central obesity. The clustering of these factors indicates the presence of both
prothrombotic and proinflammatory states. When present, MetS increases by
twofold the likelihood of developing CVD, and for T2DM, fivefold (6).
Approximately 34% of US adults over the age of twenty are believed to have
MetS (7). According to a recent update on the revised guidelines of the Third
Report of The National Cholesterol Education Program (NCEPIII), MetS patients
have an average 10-year risk for a first CHD event of up to 18%; and persons
with diabetes should be treated as though it were the risk equivalent of existing
CHD (8).
An elevated level of blood low-density lipoprotein cholesterol (LDL-C) is a
risk factor that is common to both CHD and T2DM and frequently coexists with
MetS. In 2009, it was estimated that approximately 36.7 million U.S. adults have
high LDL-C levels (> 160 mg/dl), with an additional 30.8 million having borderline2

high levels ( l .160 mg/dl and >130 mg/dl) (9). NCEP III has identified that the
principal target for coronary heart disease (CHD) risk reduction is the control of
LDL-C (3).
The greatest benefit in risk reduction through the lowering of LDL-C is
derived from early intervention, because CVD develops over many years before
symptoms become apparent (10). Vascular damage occurs in stages, beginning
with the accumulation of modified LDL-C within an arterial wall. Over time, the
growing lesion can narrow the vessel lumen. Epidemiological studies have
demonstrated that LDL-C levels correlate with CVD risk, and combined analyses,
indicate that for every 1% reduction in LDL-C, there is a reduction in CHD risk of
at least 1% which is independent of baseline LDL-C levels (11-13).
The inflammatory biomarker, C-reactive protein (CRP) also is predictive
of disease outcomes in individuals and may be as important as LDL-C in terms of
risk assessment (14, 15), even in apparently healthy individuals (16), Because
vascular damage is an inflammatory process, proliferation and migration of cells
lead to plaque formation. When the expanded plaque ruptures, the vessel fills
with a thrombus, causing occlusion and can result in ischemia or infarction (17).
Arterial occlusion can occur without warning, even in asymptomatic individuals.
CRP was found to be a strong predictor of the development of T2DM in the
Nurse’s Health Study (18). In addition, that study determined that undiagnosed
vascular damage can be present for up to fifteen years before a diagnosis of
T2DM is made in women (19). Changes in dietary pattern that included a
reduced consumption of trans fats (82) and a lower ratio of n-6 to n-3 fatty acids
3

(75) have been associated with both improved LDL-C and CRP following lifestyle
intervention studies.
Risk factor modifications have been shown to reduce morbidity and
mortality from CVD (10), but it is necessary to identify those individuals at risk.
Data from the National Health and Nutrition Examination Survey (NHANES) from
1999 - 2006 show that one-third of the participants with elevated LDL-C were
previously unscreened and had missed an opportunity to improve their status.
Additionally, one-fourth of those that were screened and had elevated LDL-C,
were never told by their health care provider that their cholesterol was high (20).
Younger adults, ages 20 - 44 years had a particularly low screening rate
regardless of other risk factors (21). A study, that assessed screening rates
among 5,025 male and female adult primary care patients (mean age 47.4
years), found that only 40% were screened for LDL-C. Women, in particular,
were underscreened for several cardiometabolic risk factors. A conclusion of the
study was that health plans and clinical groups should examine screening
practices and develop plans to improve screening rates (22). It is estimated that
35% women in the United States have some form of CVD and for men, this
number is 37.6% (23).
A lifestyle that limits or does not permit the development of risk factors is
the preferred method to lower cardiovascular risk (24). However, the Health
Belief Model states that individuals must feel susceptible to a disease or
condition before they will take action to decrease their risk. This model relies on
assumptions that the individual is aware of what the hazards are in general, and
4

is able to self-assess their personal risk and confidently begin therapeutic
lifestyle change (25). Research has demonstrated that there is a general lack of
awareness of healthy levels of risk factors for CVD, and that most individuals do
not know their own degree of risk (26, 27).
Conversely, improved awareness is known to increase actions to lower
CVD risk (27). Furthermore it has been shown, that when individuals are
identified as at-risk for the development of CVD and T2DM and are shown how to
make lifestyle changes, risk can be significantly reduced (28). It stands to reason
that an intervention program designed to reduce health risks by increased
awareness and lifestyle changes could be successful and impact the progression
of either CVD or T2DM. In the case of prediabetes, an identifiable condition that
precedes the diagnosis of T2DM, lifestyle changes are shown to be even more
effective than treatment with medication (29). Interventions with the common goal
of reducing risk factor prevalence for CVD and T2DM, affect other chronic
diseases such as dyslipidemia, hypertension and obesity. A review of preventive
interventions reported that effective primary prevention treatments for T2DM are
effective in those chronic conditions, as well (30). Despite the strong evidence
supporting the promotion of a healthy lifestyle to prevent chronic disease,
dissemination and implementation of intervention programs have been
problematic because there are few options that are low-cost and commonly
accessible.
The Centers for Disease Control and Prevention (CDC) suggest that
worksites are uniquely positioned to provide effective programs that improve
5

health, because more than one-half of waking hours are spent at work.
Therefore, employees are a potential captive audience for programs that include
health screenings and educational sessions (31). In 2009, an estimated 60% of
U.S. adults older than 18 years were employed; and of those, 16% were older
than 65 years (32). In fact, worksite health promotion (WHP) has been shown to
successfully educate employees, screen, and reduce risk for the development of
chronic disease (33-37).
Goetzel et al. found that employees with modifiable lifestyle risk factors
cost employers 228% more in health care costs relative to risk-free employees
(38). Multiple studies have shown that health care costs and absenteeism are
decreased when employee’s heath risks are reduced through WHP (39). In 2005,
it was reported that participants in WHPs had 25% - 30% lower medical and
absenteeism costs compared to non- participants (40). Moreover, a 2010 meta
analysis of twenty-two studies on cost savings, associated with WHPs, found that
the average employer yielded cost-savings of $358 per participating employee in
2009 dollars (41). Because most of the studies evaluated in the aforementioned
review were implemented by large employers (more than 1,000 employees),
these positive findings might not pertain to smaller employers. Currently, eightyfive percent of U.S. employers have fewer than 100 employees (42). From the
perspective of the smaller employer, it would be important to determine not only
that an employer-sponsored wellness program improves the health of
employees, but that it is also cost-effective when compared to the potential
consequences of deteriorating employee health.
6

The purpose of the following intervention study was to evaluate the impact
and cost- effectiveness of a lifestyle intervention program on the health status of
the employees of a small (172 employee), decentralized organization. Our
worksite health promotion (WHP) assessed CHD risk in employees of University
of New Hampshire Cooperative Extension (UNHCE), and provided an
educational intervention to promote healthy lifestyle changes.
Research Objectives
A two-year intervention study of consecutive twelve-month periods was
designed to: 1) evaluate the impact and cost-effectiveness of a lifestyle
intervention program on the health status of employees of UNH Cooperative
Extension (UNHCE) in year one and, 2) determine if any positive changes in
lifestyle, clinical measurements and health risk factors achieved after 1 year in
employees of UNHCE are sustained in year two.
Methods
Randomization / Allocation
UNH Cooperative Extension is based on the UNH Durham campus;
however, it has ten additional regional worksites throughout the state of New
Hampshire. Participants were recruited from all of the UNHCE offices, sixty-four
of the 172 employees (37%, 6 male, 58 female) from ten sites volunteered.
Assignment of subjects to treatment groups was dependent on site; 18
volunteers from the five out of ten total sites that had no access to
videoconferencing were assigned, by default, to the Comparison (C) group.
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Volunteers from the remaining sites were randomized on a proportional basis to
either the Intervention (I) or C group. This allocation resulted in C and I groups of
32 subjects, each. Subjects signed an informed consent document and were not
compensated. The use of human subjects in this study was approved by the
University of New Hampshire (UNH) Institutional Review Board for the Protection
of Human Subjects in Research (IRB). Testing was conducted at county offices
of UNHCE or on the UNH campus. Comprehensive testing was performed at
baseline, twelve months and 24 months with additional blood tests at six and
eighteen months.
After randomization, but prior to baseline testing, four volunteers withdrew
from the study (2 did not want to commit to the conditions of the study, 1 job
change, 1 personal), leaving 31 C and 29 I participants at baseline. During year
one, five subjects withdrew (3 personal, 2 job change), leaving 28 C and 27 I
participants at 12 months. During year two, twelve additional volunteers (6
personal, 4 retired, 1 job change, 1 illness) withdrew leaving 23 C subjects and
20 I subjects at 24 months. (Figure 1.1).
Anthropometric and Biochemical Screening Tests
All participants were tested, using fingerstick samples of whole blood,
after an overnight fast for: total cholesterol (TC), HDL-cholesterol (HDL-C), LDLcholesterol (LDL-C), total cholesterol to HDL-cholesterol ratio (TCHDL),
triglycerides (TRG) glucose (FG) and high-sensitivity C-reactive protein (hsCRP).
Samples were analyzed enzymatically using a small, portable analyzer
(Cholestech LDX system, Cholestech Corporation. Hayward, CA).
8

Figure 1.1 Participant Allocation and Withdrawals

Participant
allocation and withdrawals

12 offices wttti volunteers
| Volunteer participants n * 44
i
(4 male, 58 female)

Post-randomizalfon

Offices assessed lor eBgibWy for Intervention
(access to videoconference network)

NO

YES

Default assignment
to Comparison group
n « 18

Participants randomized
within each office
to Comparison or Intervention group

Comparison
n « 32

Intervention
n = 32

f Withdrawals)
Before screening
Fall 2008

n -2
changed mind
Job change
personal
Comparison
n - 31

Job change
personal

Month 12

Fall 2008

Month 24

Job change
n -2
personal

Comparison
n«2»

n- 4
3 personal.
1 Illness
1 retired
1 Job change

n«4
3 personal
3 retired

Comparison
n • 23

Figure 1.1 Legend - Before allocation of subjects to experimental groups, it was necessary to assess each UNHCE
worksite individually for membership in the Granite State Distance Learning Network (GSDLN). If GSDLN was not
available, participants from those sites received a default assignment to the comparison group. Eighteen participants
from these offices were allocated to the comparison group. Since the number of volunteers from each of the offices
that were part of GSDLN was different, the random selection of fourteen comparison subjects was done on a
proportional basis, with at least one participant from each site assigned to the comparison group. This allocation
resulted in comparison and intervention groups of 32 subjects each.
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Height and weight were measured using a portable Health-O-Meter 402
medical beam scale with non-detachable weights and an 84” sliding stadiometer.
Waist circumference (WC) was measured using a non-stretchable, flexible tape
measure placed at the level of the iliac crest parallel with the floor. Measurement
was made at the end of a normal expiration.
Percent fat mass (PCTFM), total body water percent (TBWPCT), and body
mass index (BMI), were measured using a portable, battery-operated
bioimpedance analyzer BIA 450, Biodynamics Corporation, Seattle, WA). The
BMI value that is reported by the BIA 450 is based on Quetelet’s Index: W eight/
Heigh f (43).
Following BIA measurement, systolic (SBP) and diastolic blood pressures
(DBP) were measured in the right arm of subjects in the supine position, using a
clinically approved automated oscillometric monitor (Omron HEM-711 AC(N),
Omron Healthcare, Inc, Bannockburn, Illinois) according to standard protocols.
Metabolic syndrome markers were counted based on the definition of MetS
components by the NCEP ATP III. These factors included WC >102 cm. (40 in.)
for men and > 88 cm. (35 in.) for women, HDL-C < 40 mg/dl in men and < 50
mg/dl in women, TG > 150 mg/dl, BP > 130/> 85 mmHg and FG > 100 mg/dl
(44). A copy of screening test results was presented to each participant and
discussed immediately following testing.
Starting in month 5 of year one, subjects also received monthly health
newsletters by electronic mail (e-mail) in year one: and in year two, four
quarterly. Each issue had a particular focus such as, T2DM or MetS, and was
10

written so that the purpose of the material was easily understood and in a style
that was active and personal. (Table 1.1).
Pulmonary Function Studies
Since pulmonary function has been reported to be inversely related with
insulin sensitivity and WC (45, 46), each participant was given and instructed in
the use of a new, hand-held digital peak flow meter (Koko Peak Pro6, Bionostics
Inc 7 Jackson Rd, Ayer, MA 01432) that measured peak expiratory flow rate
(PEF) and forced expiratory volume in one second (FEN/^.
Participants were also given written, illustrated instructions and a printed
form on which to self-record results. They were asked to perform the test at
home in the morning and evening at the same times each day for a week in the
month following the health screening.
Measurement of PEF and FEVi was repeated three times at each testing, with
the highest value of the three recorded. Participants were asked to mail the
record sheet to the primary research investigator when completed. The use of a
handheld spirometer in research settings has been justified (47) and the
collection of three, unsupervised efforts at a time has been found to be adequate
(48).
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Table 1.1. Contents of UNHCE Workplace Health Promotion Newsletters
Volume
(ta K )

T .
To* “
•
•

.......
V o l-1 (1)

•
•
•
•

y 0 l 1 ,g\
' '

Volume
M

What are the benefits of regular
physical activity?
How to stay hydrated
If the shoe fits...
v
Your steps count
Tips for staying physically
active
Take it slow

Vol 1 (7)

T .
T° I " CS

•
•

The body’s reaction to stress
Stress increases risk of illness

*
•

Stress and exercise
Stress and sleep

•

Ways to reduce stress

•

Increasing prevalence of
diabetes

•

Risk factors for diabetes

•

•
•

Wellness: what’s in it for you?
Metabolic syndrome, heart
disease, diabetes

•

Strategies for dealing with the
holidays

•
•

Holiday recipe
Alcohol intake during the
holidays

•

Metabolic syndrome increases
diabetes risk
Diabetes prevention

•

Exercise helps!

•

Resolutions for a healthy year

•

•

Components of a healthy diet:
Carbohydrates

Identifying and modifying CVD
risk

•

Atherosclerosis

•

Important considerations for
women

•

Blood pressure, cholesterol and
triglycerides
Heart healthy diet / good fats
and bad fats

•
•

Simple vs. complex
carbohydrates
Whole grains and fiber

•

Recipe

Vol. 1 (3)

Vol. 2 (1 )

Vol. 2 (2)

•

Vol. 1 (4)

y0l j

Vol. 1 (6)

•
•
•

Dietary fats: why we need them
Good ones, not-so-good ones
Ways to add healthy fats to
your diet

•

Recipe

•
•

What are proteins?
Sources of protein

•

Meat and meat alternatives

•

Ways to add protein to your

•

The ‘skinny’ on high protein
diets

•

Recipe

•

What is osteoporosis?

•

What are the risk factors?

•
•

Dietary sources of calcium
Calcium supplements

•

Recipe

Vol. 2 (3)

Vol. 2 (4)

•
•
•

What is stress?
Mind-body connection
Stress at work

•

Stress management

•

Maintenance of a Healthy
Lifestyle

•
•

Prevent the Preventable
Why Work at Health?

•

Why Health at Work?

•

Keep it Simple

Newsletters were formatted for and delivered by email to all WHP participants. Vol. 1 = year 1, Vol. 2. = Year 2. The
newsletters can be viewed on the enclosed CD.
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Test values were compared to predicted normal values for PEF (49) and
FEVi (50) using a web-based resource, the Medical Algorithms Projects
(www.medal.org) and calculated using the equation:
Percent of predicted = (measured PEF or F E V i) / (predicted PEF or FEVi) *
100.

Measurement of diurnal variation of the PEF was calculated by using the
following equations:
PEFvar = absolute value (PEFpm - PEFam)
Average amplitude percent = (PEFvar/PEFavg) * 100
Due to a relatively poor return of completed self-reported record sheets
(18% at 12 months) permission was sought and received from the IRB to collect
a one-time observed measurement of PEF and FEVi performed in the presence
of and recorded by the primary research investigator. This observed test was
conducted at the final health screening in year two in the same manner as the
self-reported tests. The variation between the mean self-reported tests of PEF
and FEVi at 24 months and the researcher-observed tests at 24 months was
calculated as a percent of the observed measure:
Self-reported measure / researcher-observed measure *100
Diet Record Collection and Analysis
Analysis of dietary nutrients was based on self-reported three-day food
records completed at baseline, 12 months, and 24 months. Subjects were given
full instructions for keeping a food record that included printed examples and
13

picture guides for estimating food portions. Specifically, participants were asked
to record on the provided forms, all foods and beverages, including water,
consumed on three typical non-consecutive days, with one of those being a
weekend day, and to return the record to the project coordinator by mail (selfaddressed stamped envelopes were provided). Dietary data were analyzed by a
commercial software program with a 20,000+ food database (Diet Analysis Plus
8.0, Wadsworth Publishing). Analyses were performed on data sets collected for
year one (baseline to 12 months) and year two (12 to 24 months). In addition,
separate standalone analyses were performed at baseline, 12 and 24 months.
Results were reported as total grams consumed or as a percent of total
kilocalories consumed and compared to Dietary Reference Intakes (DRI) for
each individual.
Of particular interest in this investigation was energy and fat consumption,
due to their purported influence on the risk for T2DM, CVD and MetS. Total fat
intake was categorized according to fatty acid saturation (i.e., saturated,
monounsaturated, polyunsaturated) and unspecified fats. The category of
unspecified fats as defined by Diet Analysis Plus 8.0 may include any type of fat
that is not classified as saturated, monounsaturated, or polyunsaturated by a
food manufacturer or laboratory nutrient analysis, such as: trans fats, fractionated
oils, phospholipids, sterols (cholesterol), glycerol, monoglycerides, and
diglycerides. Omega-3 (n-3) and omega-6 (n-6) polyunsaturated fatty acids
(PUFAs) were also evaluated and used to calculate the n-6 to n-3 ratio (n-6/n-3
ratio) as follows:
14

n-6/n-3 ratio = n-6 PUFA gms/ n-3 PUFA gms
Analysis of a subset of diet records returned by the same participants that
completed records at both baseline and 12 months, was done to determine if
there had been changes in consumption of food group servings. The food-group
analysis was based on the portion sizes and categories of the former U.S.
Department of Agriculture Center for Nutrition Policy & Promotion MyPyramid
(www.MyPyramid.gov) as follows:
•

Fruit Group should provide 4 daily servings, or 2 cups.

•

Vegetable Group should provide 5 servings, or 2.5 cups.

•

Grain Group should provide 6 ounce-equivalents (1 ounce-equivalent
means 1 serving), half of which should be whole grains.

•

Meat and Beans Group should provide 5.5 ounce-equivalents or
servings.

•

Milk Group should provide 3 cups/servings.

•

Oils should provide 24g or 6 teaspoons.

•

Discretionary Calories: The remaining amount of calories in each calorie
level after nutrient-dense foods have been chosen.

Health Questionnaire and Exit Survey
Health Questionnaire. Self-administered questionnaires were
distributed at baseline, 12 months and 24 months. The questionnaires were
designed for use by the UNH Center for Health Enhancement (CHE) weight
management program. Questions were categorized as descriptive, quantitative,
qualitative, or participatory.
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Descriptive questions queried frequency of medical check-ups, out-ofpocket medical expenses, sick day absences, medication use and consumption
of dietary supplements. Response frequency percentages were calculated by the
following formula:
Response % = (Frequency of each response / total responses within the
treatment group) *100
Quantitative questions queried participant’s perceptions of how important
it is to them to make lifestyle changes, readiness to make lifestyle changes,
confidence in ability to make changes and levels of stress on a scale of zero to
ten. Lifestyle changes were defined as changes to improve health, such as
adjusting diet, increasing physical activity, and changing health-related
behaviors. An example of a scaled-response quantitative question follows:
Put an X on the line to show how ready you are right now, on a scale of 0 to 10,
to make lifestyle changes. (0 = not very ready, 5 = somewhat ready 10 = very
ready)
Qualitative questions were open-ended queries that asked subjects what
lifestyle changes they were willing to make, and what they perceive as barriers to
making lifestyle changes. For those open-ended responses, general themes
were identified and assigned a category code. For example, responses to the
question “What lifestyle changes would you be willing to make?” would be
assigned to one or more of eight categories: none, consume or manage a
healthier diet, increase or maintain exercise, both improve/maintain diet and
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improve/maintain exercise, manage weight, stress management, or other. Three
trained raters read the responses (identity and treatment group were blinded)
and assigned one or more codes to each. Final determination of categories for
each response was made when at least two of the three raters had assigned the
same code to a response. The code assigned by the pre-appointed referee rater
was recorded in the few instances when a response was not given the same
code by at least two raters. To determine the measure of agreement among
raters, the free-marginal kappa (Kfree) was calculated using an online calculator.
The calculator was specific for use when multiple raters are not restricted in the
number of codes that are assigned to a singular response. According to
Randolph, a kappa of .70 or above indicates adequate interrater agreement (51).
An example of a qualitative question was:
“ What things might make it hard for you to make lifestyle changes?”
At 24 months, subjects reported how participation in the WHP impacted
their lifestyle, health, and how they feel. Responses utilized a Likert-like balanced
scale. An example of a participatory question follows:
Has participation in the UNH Cooperative Extension Workplace Wellness Study
impacted your lifestyle? (stayed the same, improved a little, improved somewhat,
improved a lot, worsened a little, worsened somewhat, worsened a lot).
Because a relatively small number of responses were spread over seven
options in the participatory questions, sparse entries for some of the response
cells prevented making a meaningful statistical comparison in that form.

17

Therefore, responses were then grouped into three categories for analysis: 1)
stayed the same, 2) improved or, 3) worsened.
A complete description of results and discussion of the Health
Questionnaire will be presented in Chapter 3. Please refer to the Appendix for a
complete version of the Health and Wellness Questionnaire.
Exit Survey. An Exit survey was given at the final health screening at 24
months. The three-question survey queried changes in lifestyle and health as a
result of participation in the study and overall satisfaction with the program. An
example of an Exit question was:
As a result of participating in the UNHCE Workplace Wellness program: What
lifestyle changes (for example, healthy diet and activity choices, health
maintenance and stress management) have you made? Please be specific.
The open-ended Exit responses were treated in the same manner as
described above for qualitative questionnaire responses. A complete description
of results and discussion of the Exit Survey will be presented in Chapter 3.
Please refer to the Appendix for a list of the Exit Survey questions.
Calculations
Computation of relative and absolute changes in variables followed the
calculations of Soler et al., from their 2010 review of the effectiveness of
Worksite Health Promotions (52):
Absolute change = (lpoSt - lpre) - (Cpost - Cpre)
Relative change = [(lpost/ l pre) / (Cpost/Cpre) - 1 ] x 100%
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Where I = [mean value for intervention group], C = [mean value for comparison
group], pre = [baseline measurement], and post = [ 12-month measurement].
The cost-effectiveness ratio (C-E ratio) of the intervention was computed by
dividing the per-capita cost of the intervention by the relative percentage-point
reduction in LDL-C:
C- E ratio = Cost of intervention / Unit of effectiveness
A complete description of the cost-effectiveness analysis is discussed in Chapter
2.

Intervention
The intervention consisted of a wellness education program and the
distribution of pedometers. The C group did not participate in either component.
Wellness Education Program. The wellness education program was presented to
I participants using The Granite State Distance Learning Network (GSDLN).
GSDLN is a partnership of organizations providing an interactive
videoconferencing network across the state of New Hampshire
(http://gsdln.org/index.html). UNHCE offices that are subscribers to the network
have a meeting room equipped with the audio and video technology needed to
conduct an interactive conference. Each education module was 30 - 35 minutes
in length and presented by the investigator using PowerPoint® presentation
graphics software (Microsoft, Inc). Each presentation focused on a different
health topic such as CVD risk, diabetes, or hypertension and emphasized the
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relationship between a healthy diet and physical activity in disease prevention.
(Table 1.2).
Participants were encouraged to interact with questions and observations. In
year one, ten monthly videoconferences were presented. In year two, four
quarterly videoconferences were presented.
The presentations in year one were accompanied by food samplings
provided by volunteer facilitators at each site, at the direction of the investigator.
Foods were chosen for their nutritional benefit and ease of preparation, and also
to introduce the participants to healthy foods that might be unfamiliar or be
perceived as unappetizing. Examples included: whole-grain cereal products,
meatless dishes, reduced-fat dairy products, healthy snack options, and a variety
of less well-known fruits and vegetables. Participants were encouraged to email
the primary investigator with any additional questions, suggestions and to offer
evaluation of the program.
Pedometer Distribution. Intervention subjects were given a new
pedometer (Digi-Walker™ SW-401, Lees Summit, MO). Participants were
instructed to wear the pedometers during waking hours, to increase their steps to
10,000 or more daily and to report their activity totals weekly. Studies suggest
that 10,000 steps/day is a reasonable level for healthy adults to attain the health
benefits of regular exercise (53). Alternative activities, such as bicycling, were
converted to steps using a conversion table provided by the University of New
Hampshire Center for Health Enhancement. Step counts were reported weekly
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by Intervention participants only, and are presented as average steps per day per
each thirteen-week quarter of the year.
Statistics
Analyses were based on the assigned treatment at the time of
randomization, regardless of adherence, and all participants’ data were included
in the primary analyses. Data from anthropometric, biochemical, clinical, dietary,
descriptive and quantitative questionnaire responses, and frequency counts of
questionnaire and exit survey responses were analyzed using general linear
model (GLM) ANOVA for repeated measures. Anthropometric, biochemical,
clinical and dietary data were corrected for age and gender, with exception of
percent predicted pulmonary tests. A self-reported diagnosis of asthma and/or
the use of bronchodilators were entered as covariates in the GLM model for
pulmonary tests. Since values of blood hsCRP were skewed, the data were logtransformed for parametric analysis. At 12 months, data from one C group
participant was identified as being an outlier in the analysis of missed days at
work for year one. Data for this participant was omitted for that analysis only.
Post-hoc analyses were conducted using Tukey’s Honestly Significant
Difference test. Pearson’s Chi square analysis was used to examine
questionnaire descriptive responses, individual categories of qualitative
responses, and same vs. improved participation questions. Data are presented
as mean ± SE, unless indicated otherwise. The level of statistical significance
was set at p < 0.05. Statistical analyses were performed using SYSTAT 12 ©
Copyright 2007, SYSTAT Software, Inc.
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Table 1.2. Topics Included in UNHCE Workplace Health Promotion Educational Sessions
Year 1
Introduction/ Proper footwear

Physical Activity / Pedometers / Hydration

Healthy Living / Healthy Eating / Healthy Body

Carbohydrates

About Fats -

Protein and Meat Alternatives

Healthy Bones2

•

Introduction to Workplace Health Promotion

•
•
•

Schedule for sessions
Choosing the proper exercise shoe for you1
Question and answer session

•

Benefits of regular physical activity

•
•

Keeping hydrated
Why use pedometers

•
•
•

Pedometer questions
Smart Holiday Choices
Question and answer session

•

Snack- green tea

•
•
•

How lifestyle makes a difference
Get ready for the holidays
Obesity facts and statistics

•
•

Comorbidities of obesity
Energy balance for weight loss

•

The Holidays and Your Health: Alcohol

•
•

Holidays at the Office
Question and answer session

•

Snack - spiced oranges

•
•

Diet resolutions
What is a healthy diet?

•
•
•

Carbohydrates ~
Simple VS Complex
Whole grains/Fiber

•
•

Low-carbohydrate diets
Question and answer session

•

Snack- whole grain crackers, breads with hummus

•
•

What fats are and why we need them in our body.
The good ones, and the not so good ones.

•

Benefits of healthy fats.

•
•

Easy ways to add healthy fats to your diet!
Question and answer session

•

Snack - low-fat or fat-free cheeses

•
•

What are Proteins?
Sources of Protein

•

Meat & Meat Alternatives

•

Importance of non-meat sources of proteins

•
•

Easy ways to add healthy protein to your diet
Question and answer session

•

Snack - meatless chili

•

Implications of osteoporosis

•
•

Risk factors / Diagnosis
Current and future treatment

•

Resistance exercise

•

Question and answer session

•

Snack -Spinach dip with fat-free sour cream
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Table 1.2, continued

Stress

Fruits, Vegetables and “Functional” Foods

•

Prevalence of Stress

•
•
•

The body’s reaction to stress
Risks of Chronic Stress
Connection between stress and sleep

•
•
•

Connection between stress and exercise
Coping with stress
Question and answer session

•

Herbal tea

•
•

Fruits and vegetables reduce disease risk
Antioxidants and phytochemicals

•

How much should I eat?

•
•
•

“What’s that?” quiz ( novel fruits and vegetables)
Tips to Eat More (fruits and vegetables, that is!)
Question and answer session

•

Snack- star fruits, Asian pears, rainbow carrots

Year 2

Diabetes and Prediabetes - Opportunity for
prevention

Heart Disease Risk

Stress management

Maintenance of a healthy lifestyle

•
•
•

What is diabetes?
Complications of diabetes
Prevention of diabetes

•

Lifestyle modification

•

Modifiable risk factors

•

How adiposity contributes to diabetes risk

•
•

Metabolic syndrome
Pre diabetes and the “ticking time bomb”

•
•
•

Resolutions for a healthy year
Workplace wellness program goals
Be active!

•
•

Atherosclerosis
Function of cholesterol in the body

•
•
•

NCEP-III recommendations
Dietary fats
CVD risk factors

•

Women’s risk

•
•

What is stress?
Mind - Body Connection

•

How it works - stress response

•
•

Chronic stress
Speaking of work...

•

Stress reduction

•

Why work at health?

•

Preventing the preventable

•

Healthy employees save money, and so do their employers

'Presented by Certified Athletic Trainer, Presented by guest graduate student in Nutritional Sciences
One-hour sessions were presented using Powerpoint® and delivered simultaneously to all sites using
videoconferencing and were followed by discussion, questions and answers, and food tastings when appropriate for
topic.
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Results
Lipids. Glucose. hsCRP
No differences in baseline measures were found between groups in age,
anthropometric and biochemical screening tests or markers of metabolic
syndrome. (Table 1.3).
At 12 months, LDL-C of the I group had a decrease from baseline and was
significantly less than that of the C group (110.86 ± 4.4 mg/dl, 126.67 ±4.0 mg/dl
respectively, p = 0.011). TC of the I group decreased significantly from baseline
at 12 months, and also was less than that found in the C group at 12 months
(183.4 ± 4.4 mg/dl, 198.6 mg/dl, respectively, p = 0.001 within group, 0.013
between groups). TC of the C group was not different from baseline at the end of
one year. No other within-group or between-group differences in, HDL-C,
TC/HDL, TRG, FG or hsCRP were found at 12 months.
At 24 months, hsCRP of the I group was 44% less than that of the C group
at 24 months (p = 0.027). TC and LDL-C were not statistically different from the
12 month to 24 month value, either within-group or between-groups; nor were
any within-group or between-group differences observed in, HDL-C, TC/HDL,
TRG, or FG.
During year one and year two, fasting lipids and glucose also were
measured at six-month intervals (months 6 and 18). When analyzed at months 0,
6, and 12, TC of the I group showed a significant decrease from baseline (205.27
± 4.4 mg/dl, 188.01 ± 4.7 mg/dl, p = 0.017). No within-group or between-group
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differences in TC were measured in the C group. No within-group or betweengroup differences in other lipids were found. In year two, no differences in lipids
were seen either within-group or between groups in six-month intervals of 12, 18
and 24 months.
At six months, FG increased significantly from baseline in both C and I
groups (increases of 8.9 mg/dl, 7.6 mg/dl, respectively, both p = 0.001 from
baseline) but, when analysis of FG was repeated adding season as a covariate,
statistical differences were abolished for year one. In year two, no between
group or within group differences in FG were found. When season was added as
a covariate to the year two analysis, a between group difference in FG (C = 89.8
± 1.8 mg/dl, I = 95.9 ± 1.9 mg/dl, p = 0.038) at eighteen months was observed
that was not present at either 12 or 24 months.
Waist Circumference. Blood Pressure. Body Composition
At 12 months, there was no change in WC of the I group but, the mean
WC of the C group increased significantly from baseline, (37.1 ±0.4 vs.38.9 ± 0.4
in, respectively, p= 0.001). The difference in WC between groups at 12 months
was not significant. No other within-group or between-group differences in
weight, BMI, PCTFM, TBWPCT, SBP or DBP were observed at 12 months.
At 24 months, WC of the I group (37.3 in) was significantly less than the C
group (38.7 in, p = 0.04). No other within-group or between-group differences in
blood pressure or measures of body composition were observed at 24 months.
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Metabolic Syndrome Markers
The mean number of MetS markers increased in the C group from
baseline to 12 months (1.44 ±0.1, 1.88 ± 0.1 markers, p = 0.018), a value that
also was greater than that measured in the I group at 12 months (1.29 ± 0.1
markers, p = 0.002). No within-group difference was noted in the I group. In year
two, no within-group changes from the 12 month values of MetS were seen in
either treatment group, nor were any between-group differences measured at
either 12 or 24 months. (Table 1.3).

26

Table 1.3 Health Screening Measurements

Year 1
Comparison
Variable

Year 2
Intervention

Intervention

Comparison

Baseline

12 Months

Baseline

12 Months

12 Months

24 months

12 Months

24 months

n = 31

n= 29

n = 29

n =26

n = 29

n = 23

n = 26

n = 20

Age (years)

48.5 ± 1.8

48.5 ± 1.9

51.7 ±1.9

53.7 ±2.1

48.1 ± 1.9

48.3 ±2 .0

53.7 ±2.1

48,3 ± 2.0

Weight (lbs)

180.4 ±8.7

185.5 ±9.0

182.2 ±9 .8

181.4 ±10.1

166.8 ± 1.0

168.2 ±1.1

166.7 ±1.1

168.2 ±1.1

Body Mass Index (kgfM2)

28.0 ± 1.4

28.5 ± 1.4

29.2 ±1.5

28.8 ± 1 .6

28.2 ± 0 .3

28.4 ± 0 .3

28.1 ± 0 .3

28.4 ±0.3

Waist Circumference (inches)

37.1 ± 0.4

38.9 ±0 .4 ***

37.1 ±0.4

37.8 ± 0 .5

38.4 ±0.4

38.7 ±0.4

38.4 ± 0 .4

38.7 ± 0 .4 A

Body Fat %

31.1 ± 1.4

30.3 ± 1 .5

31.7 ±1 .5

31.2± 1.6

32.7 ± 0 .5

34.5 ± 0.6

32.8 ± 0 .6

34.5 ± 0 .6

Body water %

49.5 ± 1.1

50.4 ± 1.1

49.3 ±1.1

49.4 ± 1.2

48.9 ±0.4

47.2 ± 0.4

48.7 ± 0 .5

47.2 ± 0.4

Systolic Blood Pressure (mm/Hg)

125.6 ±1 .5

131.0 ±1.6

125.6 ± 1.7

130.9 ±1 .8

131.4 ± 1.5

131.8 ± 1.6

133.0 ± 1.8

131.8 ± 1.6

Diastolic Blood Pressure (mm/Hg)

84.6 ±2.1

82.7 ±2.1

87.8 ±2 .2

87.0 ±2 .4

80.2 ± 1.0

81.1 ±1.1

81.2 ± 1.3

81.1 ±1.1

Total Cholesterol (mg/dl)

200.1 ±3.7

198.6 ±3.9

201.8 ± 4 .0

183.4 ± 4.4 *** A

186.9 ±2 .6

190.5 ±2.8

186.3 ±3.0

190.5 ±2.8

HDL-C (mg/dl)

54.7 ±3 .0

48.1 ± 3.2

53.1 ±3 .3

48.2 ± 3 .5

51.0 ± 1.2

54.4 ± 1.3

50.6 ± 1 .5

54.4 ± 1.3

Triglycerides (mg/dl)

145.7 ±15.7

153.8 ± 16.3

156.7 ± 16.8 142.8 ±18.2

114.0 ±7 .4

98.3 ± 8.0

108.1 ± 8 .5

98.3 ±8.0

LDL-C (mg/dl)

121.0 ±3 .7

126.7 ±4.0

122.3 ±3 .9

110.9 ± 4.4 A

116.5 ±2 .4

117.1 ±2.9

117.3 ±2.8

117.1 ±2.9

TC/HDL

4.1 ± 0.2

4.4 ± 0.3

4.4 ± 0.3

4.4 ± 0 .3

4.0 ± 0.09

3.9 ± 1.0

4.1 ±0.1

3.9 ± 1.0

Fasting Glucose (mg/dl)

88.5 ± 1.3

92.0 ± 1.3

90.1 ±1.4

90.6 ± 1.5

91.5 ± 1.5

92.0 ± 1.6

91.9 ± 1.8

92.0 ± 1.6

hsC-Reactive Protein (mg/L)

2.2 ±0 .3

2.8 ±0 .3

2.2 ±0 .3

2.9 ±0 .3

2.6 ± 0.4

2.9 ±0 .5

2.6 ±0 .5

2.9 ± 0.5 A

Metabolic Syndrome Markers

1.4 ±0.1

1.9 ± 0 .1 *

1.5 ±0.1

1.3 ±0.1 AA

1.8 ±0.2

1.8± 0.2

1.3 ±0.3

1.8± 0.2

* p s 0.05 within group, ** p s 0.01 within group, " * p s 0.001 within gro u p ,A p s 0.05between groups,AA p s 0.01 between groups,AAA p £ 0.001 between groups
All variables except age and Metabolic Syndrome Markers corrected f a age and sex. Statistical analyses were perfamed by general linear model using SYSTAT 12.
Post hoc analysis was performed using Tuke/s Honestiy-Significant-Difference Test. Statistical significance was set at p ^ .05

Pulmonary Function Studies
Baseline values for the percent predicted value of FEVi (^opredFEV!) and
the percent predicted value of PEF (%preciPEF) were not different between
groups. No differences were found between or within groups at 12 months in
either %predFEVi or %predPEF. At 24 months, the mean self-reported %predFEVi
in the I group was greater than that of the C group (99.1 ± 2.2%, 88.8 ± 2.6 %, p
= 0.024), and the mean self-reported %predPEF was not different between groups.
No within-group differences were found in either self-reported %predFEVi or
%PredPEF at 24 months. No differences between groups or within groups were
noted in diurnal variation in FEN^ at 12 or 24 months.
At the study exit, the researcher-observed % predPEF of the C group was
lower than in the I group, but, was not significantly different (73.2 ± 6.1%, 81.5 ±
5.3% . p = 0.1). The researcher-observed %predFEV1was not different between
groups. The self reported pulmonary values of the combined cohorts (all
participants) were correlated to those measured by the researcher at study exit..
(Table 1.4). Complete pulmonary function test results can be found in the
Appendix.
Correlations among clinical findings
During years one and two, WC correlated significantly with hsCRP, r =
0.56 ( year one); r = 0.50 ( year two) p < 0.001. In year one, hsCRP also was
found to correlate with LDL-C r = 0.31 p = 0.004 and WC correlated negatively
with HDL-C, r = -0.33. p = < 0.001.
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Table 1.4 Correlation of Self-reported with Researcher-observed Exit Pulmonary
Function Tests
Variable pairs

r

P

FEV1 Self- reported

FEV1 Exit

0.659

0.06

PEF Self- reported

PEF Exit

0.699

0.024

% PRED FEV1 Self- reported

% PRED FEV1 Exit

0.761

0.004

% PRED PEF Self- reported

% PRED PEF Exit

0.752

0.006

FEV1 - forced expiratory volume in 1 second, PEF - Peak expiratory flow rate
% PRED FEV1, % PRED PEF - Test values were compared to predicted normal values for PEF (49) and FEVi
(50); Percent of predicted = (measured PEF or F E V i ) / (predicted PEF or FEVi) * 10
Self-reported = test values reported by participants at 24 months, Exit = values of investigator-observed tests at
study exit.
Statistical significance was set at p < 0.05

Diet Analysis
Baseline, 12 and 24 month analyses. At baseline, the percent of
unspecified dietary fats consumed was significantly greater in the I group than
the C group (9.4%, 7.0%, p = 0.02). No other between-group differences in
nutrient consumption were noted.
At 12 months, the n-6/n-3 ratio of the C group was found to be greater
than that of the I group (14.49 ±1.8; 10.33 ±2.3, p = 0.03). (Figure 1.2 ). There
were no other differences found between groups in any nutrient. No significant
differences in nutrient intakes were found in the 24 month diet analysis. However,
at 24 months, n-6 fatty acids consumption of C group tended to be higher than I
group (p = 0.09).
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Figure 1.2 Between-group Difference in Ratio of Omega-6 to Omega-3 Fatty Acids

Omega-6 / Omega-3 Fatty Acids
18
16
14

■ C o m p a ris o n
* In te r v e n tio n

C o m p a ris o n

In te rv e n tio n

12 Months

A p < 0.05
between groups

Difference between Comparison and Intervention groups at 12 months. Analyses were performed by General
Linear Model and corrected for age and gender. Statistical significance was set at p < 0.05.

Analyses bv year. In year one, energy intake from baseline decreased in the C
group (1893.4 ± 68.6 kcals; 1629.06 ±84.9 kcals, p = 0.019) and the I group
(1881.7 ±89.1 kcals, 1485.05 ± 110.5 kcals, p = 0.001) The I group also reported
a decrease in percent of unspecified dietary fats from baseline levels (8.0% ±
0.6% to 5.96% ± 0.8%, p = 0.033) (Figure 1.3), as well as grams of
carbohydrates (249.38 ± 13.4 gms to 196.19 ± 16.8 gms, p = 0.006), and iron
(16.21 ±1.1 mg to 11.94 ± 1.4 mg. p = 0.01), data are presented in the Appendix.
No other within-group differences were noted; and no between group differences
were found in any nutrient in year one. In Year two, there were no within-group or
between group differences found in any nutrient from 12 to 24 months.
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Figure 1.3 Unspecified Fat Consumption Expressed as Percent of Energy Intake
During Year One

Dietary Unspecified Fats
10

■ C o m p a ris o n
■ In te r v e n tio n

3
12 m onths

B aselin e

Year O ne

*p < 0.05
within group

Between-group and within-group differences at baseline and 12 months. Analyses were performed by General Linear
Model and corrected for age and gender. Statistical significance was set at p < 0.05.

In the subset of diet records analyzed for MyPyramid food groups
servings, a decrease in the percent of recommended grain consumption from
baseline levels was reported in the I group (99.77% ± 16.4%, 53.82% ± 16.6%, p
= 0.039). No other within-group differences were noted in either group and no
between-group differences were found for any food group.
Dietary changes and clinical measurements correlations. Multiple
regression analyses were used to determine which, if any, of the anthropometric
and dietary changes observed during the intervention year one could explain the
changes in LDL-C from baseline in the I group. It was found that two factors,
dietary n-6/n-3 fatty acids and changes in percent body fat explained 41% of the
variance in the change in LDL-C (R2 = 0.41 , f (2,25) = 8.58, p = 0.001). For
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dietary n-6/n-3 ratio, intake correlated inversely; i.e., the greater the reduction in
the ratio of n-6 to n-3 fatty acids, the greater the improvement in LDL-C
concentration in year one (r = -0.51, p = 0.003). For PCTFM, the correlation was
positive ( r = 0.42, p = 0.011) with the change in LDL-C. (Figures 1.4A and
1.4B). Furthermore, in year one, grams of dietary n-6 fatty acids positively
correlated with grams of dietary saturated fatty acids ( r = 0.42, p = 0.024) and
grams of dietary fiber consumption correlated negatively with WC ( r = -0.29, p =
0.03). Complete Diet Analyses results can be found in Tables 1.5 and 1.6.
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Figure 1.4 Correlations of Year One Change in LDL-C and Dietary and Anthropometric Variables

A. Correlation of Year One Dietary Omega Fatty Acid Ratio
with the Change in LDL-C

B. Correlation of the Year One Change in Body Fat Mass
with the Change in LDL-C
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Fig. 1. 3A Dietary n-6/n-3 ratio, intake correlated inversely: i.e.. the greater the reduction in the ratio of n-6 to n-3 fatty acids, the greater the improvement in
LDL-C concentration in year one (r = -0.51. p = 0.003). Figure 1. 3B Decrease in percentbody fat correlated positively with the change in LDL-C (r = 0.42. p
= 0 .0 1 1). Statistical significance was se ta tp £ 0.05.

Table 1.5 Year 1 Diet Analysis
Comparison

Variable
Baseline

Intervention

12 m onths

CVJ
C\J
II
c

(n =18)

Baseline
(n = 21)

12 m onths
(n = 13)

Carbohydrate (% of kcals)

48.2 ± 2.1

49.1 ± 2.4

49.1 ± 2.6

50.2 ± 2.9

Protein (% of kcals)

16.3 ± 1.3

17.7 ± 1.4

16.5± 1.6

16.6 ± 1.8

Fat (% of kcals)

34.2 ± 1.8

33.3 ± 2.0

34.3 ±2.2

32.4 ± 2.5

Saturated fat ( % of kcals)

11.5 ± 0.8

11.0 ± 1.0

10.5± 1.0

10.5 ± 1.2

Monounsaturated fat (% of kcals)

9.5 ± 2.0

13.0 ± 2.3

8.7 ±2.4

8.7 ± 2.8

Polyunsaturated fat (% of kcals)

5.6 ± 0.5

6.4 ± 0.6

5.3 ± 0.7

5.9 ± 0.8

Unspecified fats (% of kcals)

7.1 ± 0.5

6.6 ± 0.6

8.0 ± 0.6

6.0 ± 0.8*

Energy (kcals)

1893.4 ± 68.6

1629.1 ± 84.9*

1881.7 ± 89.1

1485.0 ± 110.5***

CHO (gms)

247.6 ± 10.5

221.8 ± 12.9

249.4 ± 13.4

196.2 ± 16.8**

Fat (gms)

74.8 ± 6.8

76.0 ± 7.7

79.2 ± 8.4

68.8 ± 9.5

Protein (gms)

78.2 ± 3.3

68.4 ± 4.0

78.1 ±4 .3

66.7 ± 5.2

Saturated fat (gms)

28.0 ± 2.4

26.5 ± 2.7

27.7 ± 2.9

26.1 ± 3.3

Monounsaturated fat (gms)

26.0 ± 2.2

22.8 ± 2 .5

24.6 ± 2.7

20.5 ± 3 .0

Polyunsaturated fat (gms)

13.1 ± 1.3

14.4 ± 1.4

13.9 ±1.6

13.2 ± 1.8

Cholesterol (mg)

316.0 ± 3 0 .6

299.6 ± 35.0

314.7 ±38.1

344.1 ± 43.2

Omega-6 fatty acids (gms)

9.0 ± 1.0

10.5 ± 1.2

9.6 ± 1.3

8.9 ± 1.5

Omega-3 fatty acids (gms)

0.7 ± 0 .2

0.8 ± 0.2

0.9 ± 0.2

0.7 ± 0.3

Omega-6 / Omega-3 ratio (n)

14.4 ± 1.4

15.3 ± 1.6

13.6 ± 1.7

12.0 ± 1.9

Fiber (gms)

24.5 ± .41

23.5 ± 1.7

25.2 ± 1.7

20.1 ± 2.1

Sugar (gms)

95.5 ± 6.4

83.6 ± 7.8

95.4 ±8.0

84.7 ± 9.9

CA (gms)

817.4 ± 93.3

726.6 ± 106.6

730.1 ±116.0

611.6 ± 131.3

FE (gms)

16.0 ± 0.9

15.1 ± 1.1

16.2 ± 1.1

11.9 ± 1.4**

Mg (gms)

282.9 ± 24.3

263.1 ± 27.7

267.5 ± 30.2

274.1 ± 34.2

K (gms)

2579.6 ± 182.0

2495.6 ± 207.9

2690.6 ±2 2 6 .4

2755.3 ± 256.2

Zn (gms)

10.5 ± 1.0

9.5 ± 1.1

9.2 ± 1.2

9.6 ± 1.4

NA (gms)

3072.8 ± 196.3

3172.3 ± 224.3

3136.0 ± 244.3

2824.0 ± 276.4

* p < 0.05 within group, ** p < 0.01 within group, *** p < 0.001 within group
Diet analysis was performed using Diet Analysis Plus 8.0 using 3-day self-reported diet record. All variables corrected
for age and sex. Statistical analyses were performed by general linear model using SYSTAT 12. Post hoc analysis was
performed using Tukey's Honestly-Significant-Difference Test. Statistical significance was set at p < .05
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Table 1.6 Year 2 Diet Analysis
Variable

Comparison

Intervention

12 m onths

24 m onths

(n = 18)

(n = 17)

c

Carbohydrate (% of kcals)

50.0 ± 2.1

50.7 ± 2 .1

51.4 ±2.6

53.2 ± 2.5

Protein ( % of kcals)

17.7 ± 1.5

16.1 ± 1.5

16.5 ± 1.9

14.9 ± 1.8

Fat ( % of kcals)

31.6 ±2.1

32.2 ± 2.2

30.2 ±2.6

31.0 ± 2.5

Saturated fat (% of kcals)

10.7 ± 0.9

10.6 ± 0.9

10.2 ± 1.2

10.2 ± 1.1

Monounsaturated fat (% of kcals)

12.7 ± 3.0

7.5 ± 3.0

7.1 ± 3.5

7.6 ± 3 .3

Polyunsaturated fat (% of kcals)

6.1 ± 0.7

5.3 ± 0.7

5.5 ± 0.9

4.6 ± 0.8

Unspecified fats ( % of kcals)

7.1 ± 1.1

8.5 ± 1.1

7.4 ±1.4

7.7 ± 1.3

Energy (kcals)

1888.5 ± 134.1

1971.6 ± 135.3

1865.7 ± 165.5

1829.1 ± 155.7

CHO (gms)

238.8 ± 18.3

257.5 ± 18.5

248.1 ± 22.6

249.4 ± 2 1 .3

Fat (gms)

71.3 ± 7 .3

72.8 ± 7.4

64.0 ±9.1

63.2 ± 8.5

Protein (gms)

77.0 ± 5.8

79.4 ± 5.9

78.6 ± 7.2

70.5 ± 6.8

Saturated fat (gms)

23.3 ± 2.9

23.6 ± 2.9

21.9 ± 3.6

20.6 ± 3.4

Monounsaturated fat (gms)

14.6 ± 2 .7

14.8 ± 2 .7

12.6 ±3.2

13.2 ± 3 .0

Polyunsaturated fat (gms)

13.1 ± 1.5

11.8 ± 1.6

11.3 ± 1.9

10.0 ± 1.8

Cholesterol (mg)

257.3 ± 33.0

220.7 ± 33.3

277.6 ± 40.7

230. 9 ± 38.3

Omega-6 fatty acids (gms)

9.6 ± 1.3

8.1 ± 1.3

7.7 ± 1.6

6.8 ± 1.5

Omega-3 fatty acids (gms)

0.8 ± 0.3

0.6 ± 0.3

0.6 ± 0.3

0.5 ± 0.3

Omega-6 / Omega-3 ratio (n)

15.0 ±2 .1

15.5 ± 2.2

11.6 ± 2.6

14.8 ± 2.4

Fiber (gms)

20.5 ± 5.4

27.9 ± 5.4

20.3 ± 6.7

16.4 ± 6 .3

Sugar (gms)

87.3 ± 9.8

98.5 ± 10.0

94.3

93.0

CA (gms)

675.2

964.3

632.4 ±189.6

688.3

FE (gms)

13.6 ± 2 .2

15.2 ± 2 .2

15.1 ±2.7

14.1

Mg (gms)

254.4 ± 26.9

257.0 ±27.1

263.9 ±33.2

224.2 ± 3 1 .2

K (gms)

2498.4

2573.0

2627.8 ± 237.4

2394 .5 ± 2 1 7 .4

Zn (gms)

8.6 ± 1.6

8.8

7.0

NA (gms)

2795.2

±

185.9

±

188.7

9.4 ± 1.7
254.0

2847.6

±

247.5

±

±

12.7

2.0

2308.5 ±334.5

24 m onths

±

-2

3*
n

it

±

155.1

±

CO

153.1

±

12 months

11.7

±

177.3

±

2.5

±

1.9

2489.3

±

302.3

Diet analysis was performed using Diet Analysis Plus 8.0 using 3-day self-reported diet record .All variables corrected
for age and sex. Statistical analyses were performed by general linear model using SYSTAT 12. Post hoc analysis
was performed using Tukey's Honestly-Significant-Difference Test.. All variables NS between or within groups.
Statistical significance was set at p < .05
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Intervention Step Counts
Only female participants reported steps. Twenty participants reported baseline
values. At the end of year one, the number of participants in the I group that
reported steps was fourteen (54% of I group). A separate analysis at baseline
and at each quarter found no significant differences in the mean number of steps
of those participants who reported steps for all four quarters, and those that did
not
During year one, average steps per day increased significantly from baseline
(5253 ± 368 steps/day) by the second quarter, and continued at that level for the
duration of the year (7149 ± 400 steps/day, p = 0.01). (Figure 1.5). At the end of
year two, the number of reporting participants dropped to four. During year two,
the average steps per day remained unchanged from the end of year one (7010
± 367 steps/day). Complete Intervention step data can be found in the Appendix.
Figure 1.5 Year One Average Intervention Group Steps per Day
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Wiithin-group differences in steps/day at baseline and each quarter-year during year 1. Analyses were performed by
General Linear Model and corrected for age.Data re presented as LSM ± SE. Only female participants reported steps.
Statistical significance was set at p < 0.05.
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Discussion
Findings of the present study show that a WW program of monthly
education sessions was effective in producing a decrease in TC and LDL-C in
the I participants and preventing the increase in WC and MetS markers seen in
the C participants in year one. Moreover, the quarterly education sessions in year
two were sufficient to sustain the improvements in lipids seen in year one and
promote additionally identified decreases in hsCRP and WC in the I group.
Lipid improvements
Having a high level of LDL-C is a major risk factor for CVD and the
decrease of 8% in TC and 13% in LDL-C (from baseline and relative to the C
group) found in the I participants of the present study suggests a reduction in
CVD risk. Lifestyle modifications that include adjustment of dietary fat intake,
increased physical activity and weight control can decrease LDL-C by up to
30%(13). Our finding of reduced LDL-C is consistent with previous investigations
of lifestyle change that reported LDL-C reductions of 5% - 28% (54-56).
On the other hand, our results are in contrast to those referenced in a
recent review by Groeneveld, et al. (57). In some cases of earlier worksite
investigations, it was noted that either total or LDL cholesterol was not different
from controls following an educational intervention. The educational interventions
reviewed were aimed at improving lifestyle behaviors, although differed from
each other and the present study in length of intervention; 12 weeks (58), 6
months (59), and 12 months (60). The study design in all of the aforementioned
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studies, were somewhat similar to ours in that the interventions included
enhanced educational components in addition to the screening with minimal
information received by all study participants. However, the educational
components varied widely in that they consisted of private counseling (61), four
group sessions (59), or monthly individual sessions along with group classes
(60). Additionally, two of the study populations were limited to individuals with
elevated cholesterol levels (59, 60), and one to individuals diagnosed with angina
(58). The differences in findings of the present study from those cited may have
occurred due to the frequency, duration, style, or content of the interactive
educational sessions. However, it is possible that the improvement seen among
the I group in our study in total and LDL cholesterol might also be partially
attributed to the health status of the study population. The subjects of the current
study were not recruited or screened for the presence or absence of CVD risk
factors, and were considered in relatively good health. This supports the
interpretation that a WHP that promotes healthy lifestyle practices is a
preventative effort that can help to preclude the hazard of modifiable disease
among employees without previously identified risk factors.
Waist Circumference and Metabolic Syndrome Markers
Waist circumference is a surrogate measure of abdominal fat mass, and is
independently associated with cardiometabolic disorders (62, 63). It is now
understood that abdominal fat mass as measured by WC is a more significant
risk factor for CVD than total adiposity, per se (64). Although the percentage total
body fat mass was not found to be different between or within groups in the
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present study, WC in the C group increased significantly in year one, and was
larger yet at 24 months. In contrast, a non-significant decrease in WC of the I
group resulted in a significant difference from the C group at 24 months.
We did not observe any statistical changes or differences in BMI or total
fat mass either within or between groups. However, we did find that change in fat
mass positively correlated with change in LDL-C at 12 months. In an
international, cross sectional study of 69,409 men and 98,750 women, Balkau et
al. found that there was a graded increase in the frequency of CVD with both BMI
and WC, with a stronger relationship for WC than for BMI in both genders (65).
In the present study, the number of MetS markers in the I group remained
unchanged from baseline to 24 months. This was in contrast to the C group,
where the number of MetS markers increased in year one; were greater than in
the I group, and remained elevated during year two. This is consistent with the
findings of another study of a 12 month lifestyle intervention in dysmetabolic
individuals that showed an increase in MetS components in the control group. Bo
and Ciccone reported that metabolic deterioration in the intervention group of
their study was prevented, in part, due to a decreasing WC and BMI (66). That
study differs from ours in that the subjects received individually- prescribed diet
and exercise recommendations. We also did not identify a decrease in BMI in our
I group. However, sample size and insufficient statistical power could account for
the dissimilarity in findings. The decrease of 0.29 Kg/M2 in the BMI of the 169
intervention subjects in the aforementioned study was sufficient to be statistically
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significant, while a decrease of 0.38 Kg/M2 in the BMI of the 26 intervention
group subjects in the present study was not.
The prevalence of MetS in adults is increasing and there is an abundance
of evidence that individuals with MetS double their risk of CVD (6). In crosssectional investigations of both a general population and a cohort at-risk for
diabetes, the prevalence of the MetS increased with increasing age among
women (67). Epidemiological research has shown that CVD mortality risk nearly
doubles in those with even 1 or 2 MetS markers compared to those who have
none (68).
The presence of MetS markers can indicate a general decline in wellness,
or pre-disease, among employees. In a worksite study of over 5,000 employees,
it was found that as the number of risk factors increased, there was an increase
in absenteeism and illness days (69). In 2009, Schultz and Edington reported,
that during the two-year span of their risk appraisal study of approximately 3300
manufacturing workers the prevalence of MetS increased. They also found that
those employees with MetS were more likely to report new cases of heart
disease, diabetes and other chronic diseases (70).
The impact of the intervention treatment on WC and MetS markers of the
present two year investigation is noteworthy considering that the participants
were relatively healthy and of similar age at the start; and were given only
generalized lifestyle recommendations.
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Inflammation
It is now recognized that inflammation is an important etiological element
in MetS and CVD risk (71). In the present investigation, we found that hsCRP
was reduced in the I group at 24 months from 12 months and less than that seen
in the C group. In addition, WC and LDL-C were both positively correlated with
hsCRP in our entire study cohort. This association is similar to the results of a
cross-sectional study in men that investigated the relationship of hsCRP levels of
a low or moderate range and determinants of MetS (72). That study showed a
significant positive correlation between hsCRP, BMI and LDL-cholesterol among
other indicators of MetS. A positive correlation between WC, markers of
inflammation, as well as insulin resistance has been found in women with MetS
(32). These findings suggest that a variety of components of the MetS are
associated with elevated hsCRP levels in both genders.
The crucial mediators of metabolic syndrome and obesity-related
inflammation have been identified as a complex set of chemical messengers that
reside in the abdominal depot of total adipose tissue (73). Recent investigations
have provided evidence that a reduction in markers of inflammation and insulin
resistance occurs following weight loss. A review of 33 weight-loss intervention
studies that reported measuring CRP found that, in all studies, weight loss was
linked in a linear fashion decline in CRP level (74). In a separate study, CRP was
decreased and insulin sensitivity improved following weight loss and a reduced
waist-to-hip ratio in 60 obese women over two years (75).
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Pulmonary Function Tests
Reduced pulmonary function has been associated with increased body fat
mass, cardiovascular disease; and it has been shown to predict the development
of insulin resistance (45, 76, 77). Interestingly, increased WC (a risk factor of
insulin resistance) and not BMI, has been found to be negatively associated with
pulmonary function in normal weight, overweight and obese subjects (46). Given
these links, our study sought to identify a relationship between indices of
abdominal obesity and pulmonary function. In the present investigation we did
not observe a significant relationship between WC or the markers of MetS and
pulmonary function.
However, it was noted at 24 months that the self-reported percent of
predicted FEVi was greater in the I than in the C group. The test means of both
groups at that time were above the specified cut-off predicted value (80%)
thereby indicating normal pulmonary function in both cases (78). The results of
the observed testing performed by the study investigator during the Exit testing
were somewhat different, but correlated closely to those that were self-reported
by the participants at 24 months. Investigator observed testing of 91% of all
participants at the end of the study resulted in measures similar to those of the
self-reported tests, but were not significantly different between groups.
In a randomized sample of 2,153 men and women aged 35 - 79 years, it
was found that the percent predicted FEVi was inversely associated with WC in
both men and women (79). It should be noted that in the above study, the
relatively small differences in percent predicted FEVi were found across four
42

quartiles of WC, for both men and women. Our return rate of airway test
measurements from participants was poor at 12 and 24 months (15% and 40%,
respectively). It is likely that the number of reports at 12 months, coupled with a
small subject pool, did not provide enough statistical power to identify
differences, trends, or associations, if present.
Dietary pattern link to inflammation
Dietary changes that occurred in the I group of the current investigation
indicated a modification in fat intake that is associated with reduced CVD risk and
inflammation. At the end of year one, the I group reported a decrease in intake of
fats that were categorized by the diet analysis software to include trans fats. In
addition, the intake of dietary n-6 to n-3 fatty acid ratio was less in the I group
than the C group, and the n-6 to n-3 ratio was a significant predictor of the
decrease in LDL-C that occurred in year one. Further analysis showed that
intake of n-6 fatty acid intake was correlated directly with saturated fat
consumption. At 24 months, intake of n-6 fatty acids was greater among C than I
group. In year two, hsCRP was found to significantly increase within C group and
WC was found to be greater than I group at 24 months.
According to the American Heart Association Nutrition Committee, multiple
dietary factors influence CVD risk, but, the most influential factors in LDL-C
concentrations are saturated and trans fatty acid intakes (80). In a clinical trial of
varying levels of trans fat consumption, the diet with the lowest concentration of
trans fat was associated with a reduced LDL-C of 12% (81), a result that is
consistent with the 13% relative reduction in LDL-C seen in the present study.
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We did not measure any differences in the consumption of saturated fats.
However in year one, the correlation of dietary n-6 fatty acids with saturated fat
intake in our study suggests higher a consumption of saturated fats in
participants who also consumed higher amounts of n-6 fatty acids. This finding
could infer that the C group intake of saturated fats was, on the whole, higher
than of the I group due to their higher n-6 to n-3 fatty acid ratio at 12 months and
a higher n-6 fatty acid intake at 24 months.
In addition to the negative impact that trans fatty acids have on LDL-C
concentrations, there is evidence that they are also linked to inflammation. In a
cross-sectional examination of data from relatively healthy women from the
Nurse’s Healthy Study cohort, it was found that CRP levels were 73% higher
among those that had the highest trans fatty acid intake (82). On the other hand,
dietary strategies that include n-3 fatty acids, reduced trans and saturated fats
are associated with reduced inflammation (83).
*

The ratio of dietary n-6 to n-3 fatty acid intake also is linked to
inflammation. A recent review suggests that the two families of polyunsaturated
fatty acids (PUFAs) appear to have reciprocal effects on inflammation; n-3 fatty
acids being anti-inflammatory, while n-6 fatty acids are proinflammatory (83).
Consistent with the results of the present investigation, Guebre-Egziabher, et al.
found that a reduced n-6 to n-3 ratio achieved with simple dietary counseling,
was sufficient to attain significant reductions in LDL-C and inflammatory proteins
(84). Similarly, a 2 year clinical trial of otherwise healthy obese women who
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reduced dietary energy, saturated fat, and had a lower ratio of n-6 to n-3 fatty
acids than control subjects, reduced CRP (75).
The physiological response to dietary changes intended to reduce
inflammation may differ based on the degree of adiposity. A cross-sectional study
of overweight and lean subjects found that dietary n-3 fatty acids were correlated
negatively with CRP; and n-6 fatty acids were correlated negatively with another
inflammatory marker, 11-6, but only in the overweight group (85). These findings
are somewhat different with those of another study of a non-overweight
population that reported an inverse association of both plasma n-6 and n-3 fatty
acids with both CRP and IL-6, but a strong positive relationship to both markers
with the ratio of n-6 to n-3 fatty acids (86). The results of the present investigation
suggest that the metabolic profile of the C group (CRP and WC greater than that
of the I group) was associated with a higher consumption of n-6 to n-3 fatty acid
ratio than the I group.
Physical Activity
Reductions in cholesterol (87), components of MetS (88), adiposity (89),
and CRP (90) have been linked to physical activity by using pedometerdetermined walking. Gregg,et al. found that diabetics who walked at least 2 hours
per week had reduced CVD mortality rate by 34 percent compared with inactive
individuals (91) In addition, multiple studies report that there is a linear
relationship in observed changes in clinical variables such as BMI, WC,
components of MetS (92, 93) and body fat (88) to the number of steps walked
daily. At 12 months, the I participants reported a mean of 6878 ± 456 steps/day,
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although, they were encouraged to walk 10,000 steps/day. Alternatively, it was
strongly suggested that they increase their daily step count from baseline or
participate in other regular, aerobic activity. According to Tudor-Locke and
Bassett, while 10,000 steps/day appears to be a reasonable estimate of daily
activity for apparently healthy adults, health benefits of activity and its
sustainability may be more related to incremental improvements relative to
baseline values (53). Step data for year one in the present study indicated that
50% of the I group increased daily step counts significantly by 30% daily
compared to baseline; and maintained that activity level during year one.
The present findings are similar to the mean increase of 2183 steps/day
reported in a 2007 review of 18 observational studies (mean duration 18 weeks)
of pedometer use, physical activity and health outcomes (94). Since the overall
mean improvement in pedometer-measured physical activity in that review
increased by 26.9%, our results are, at least, comparable.
It is noteworthy that the mean steps/day did not decrease from 12 to 24
months. However, there was a reduction in the reporting of steps/day to 20% of
the I group over the span of 24 months. However, this is not inconsistent with
other observations. Pettman et al, compared their attrition and reporting statistics
to other lifestyle interventions. They found that the expected adherence to
exercise would be, on average, 50% (95). Hence, the compliance rate of 50% in
the first year of our study appears to be acceptable. Interestingly, 69% of the I
group reported step data for at least 13 weeks. Our compliance rate was similar
to that of another study whose authors maintain that interventions of duration
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longer than four months tend to have greater attrition. In their study, the 69%
attendance at exercise sessions achieved at four months was reduced to 50%
after the fourth month (96).
Limitations and Strengths
Limitations of this study include the reliance on self-reported information
for diet, physical activity and pulmonary function. It is not likely that the
decreased energy intake reported by our study participants accurately reflected
their usual consumption, since there was no corresponding decrease in body
weight found. Underreporting of energy intakes in diet records is common, even
when the subjects or clients have been educated in how to estimate portion sizes
and to include all food and beverages (96-98). Although misreporting may have
occurred in both the C and I groups, the differences found in fat consumption
were expressed in ratios and percentage of total intake, rather than absolute
amounts of nutrients. Therefore true accuracy of intake would have been affected
less due to underreporting. In another worksite intervention study designed to
reduce the risk of CVD, the authors concluded that since the misreporting of
dietary information occurred in both groups that bias was not introduced (99).
It is possible to detect misreporting of energy intake in weight-stable
individuals by the estimation of resting energy expenditure of the individual or
empirically by using a laboratory method such as doubly labeled water (100).
Such a method should be considered in future studies. It is also possible that
there were associations between dietary factors and clinical measurements that
were missed due to a loss of statistical power. At 12 months, there was a return
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of only 56% of diet records while baseline and 24 month diet records were
returned at a rate of 72% and 81 %, respectively. However, other studies have
reported diet record return rates as low as 33% (95). Taken together, we would
argue that underreporting did not diminish the impact of the relationships we
have described herein between dietary factors and clinical measurements.
The burden of reporting physical activity over such a long period of time
(i.e. 24 months) may have only reduced compliance with self-reporting, rather
than reduced physical activity, per se. Support for this possible interpretation is
suggested from results of responses to the Exit Survey in which the study
participants reported that more of the I group than the C group increased
physical activity (data in Chapter 3), and the sustained clinical improvements
measured in the I group over 24 months.
The usefulness of a hand-held spirometer to detect changes in relatively
healthy individuals may also be limited due to respondent burden. This
assumption is in accordance with the findings of others who report high
withdrawal rates, falsified values and poor adherence in investigations of the
accuracy of self-monitoring PEF measurements (101-103). Moreover, a known
limitation to pulmonary function is that many asthmatics have normal tests
between episodes (104).
It is possible that medication use in the few participants with diagnosed
asthma (4 at baseline, 3 at 24 months) confounded our results. However, both
the self-reported diagnosis and reported use of medications were entered into
the statistical model as covariates to account for their affect. Furthermore,
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instructions for the measurements included the qualification that testing be
conducted during a week without a cold or other respiratory ailment. It is possible
that the use of a self-recording spirometer might reduce participant burden and
provide better compliance in any future investigation.
It is possible that self-selection bias among participants occurred, since
individuals who were more motivated to make lifestyle changes may have been
more likely to volunteer. Also, our experimental design did not include a true
randomized control group. C group participants were exposed in the workplace to
the I group participants and could have emulated physical activities or dietary
patterns learned by observation.
Because all participants received their test results and newsletters,
undesirable results may have prompted private interventions outside of the
research protocol, such as clinic visits and external health or fitness programs. It
was beyond the scope of the study to control for outside influences that would
modify behaviors. Another limitation of this study was that the sample size was
small; however, participation rate was 35% of employees.
A strength of our study was the implementation of videoconferencing to
deliver simultaneous educational videoconferences, in different worksites of a
decentralized organization. Moreover, access to the videoconferences could be
broadened. For example, educational sessions might be viewed on personal
desktop computers at work, as the most up-to-date software allows for remote
internet viewing and archiving for later viewing. The use of technology can help
to ease concerns about high costs and accessibility.
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Because a small organization limits the potential pool of participants, our
study protocol did not exclude any volunteers according to the presence or
absence of preexisting risk factors. Analysis of baseline characteristics, however,
showed the population to be relatively healthy with no differences between
groups in measures of CHD risk. It could be argued that the impact of our results
is increased and could be generalized to a typical employee population.
Summary / Conclusions
As a result of participation in a WHP, the I group achieved a reduction in
total and LDL cholesterol, thereby reducing risk for cardiometabolic disease in
year one. During that year, an increase in WC and MetS markers occurred in the
C group and was avoided in the I group.
Dietary results in year one reinforce the conclusion that the I group
modified diet in a healthful manner by decreasing total and unspecified (primarily
trans) fats as well as consuming a ratio of omega-6 to omega-3 fatty acids that
was less than that of the C group. This is a beneficial outcome because both the
amount and class of dietary fats can influence the metabolic profile.
The assertion that a favorable impact on lifestyle occurred is supported by
the increased step activity, increased exercise, improved diet and lifestyle
reported by the I group. The I group subjects reported making more lifestyle and
health changes overall relative to the C group.
Changes that occurred in year one of the WHP were sustained during
year two, a period of less frequent educational sessions. Intervention education
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that persisted throughout year two may have reinforced the need for healthy
changes, or identified new changes that needed to be made since educational
material varied from year one to year two. In addition, differences in WC and
CRP that occurred at 24 months between groups may reflect that additional,
small changes occurred over time and contributed to the prevention of changes
that occur with aging.
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CHAPTER 2: COST-EFFECTIVENESS OF A WORKSITE HEALTH
PROMOTION AMONG EMPLOYEES OF UNIVERSITY OF NEW HAMPSHIRE

COOPERATIVE EXTENSION

Introduction
Chronic diseases are leading causes of death and increasing in
prevalence. These conditions are linked to modern lifestyle (1); however, lifestyle
modifications can avert these disorders (2). These conditions are predictable if
risk factors are indentified; therefore, they are also preventable (3).
Elevated blood low-density lipoprotein cholesterol (LDL-C) is a risk factor
that is associated with coronary heart disease (CHD), frequently coexists with
metabolic syndrome (MetS) and is the principal target for CHD risk reduction (3).
Studies indicate that there is a reduction in CHD risk of at least 1% for every 1%
reduction in LDL-C (4-6).
Investigators have maintained and shown that worksites are uniquely
positioned to provide health promotion that successfully reduces risk for the
development of chronic disease in employees (7-9). Employers are concerned
about financial outlay for health costs that include medical plan contributions, sick
leave, disability and worker’s compensation costs (10). Employees with
modifiable lifestyle risk factors cost employers 228% more in health costs than
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risk-free employees (11). However, costs and absenteeism are decreased when
employee’s heath risks are reduced through worksite programs (12). A meta
analysis of studies on cost-savings associated with such programs showed that
the average annual employer cost of $144 per employee represented a costsavings of $358 per participant in 2009 dollars (13). Most of the studies
evaluated were implemented in companies with more than 1,000 employees and
were centralized; it is not clear if these findings can be generalized to smaller
organizations. Since firms with fewer than 500 employees represent 99.7% of
U.S. employers, more efforts to promote workplace wellness programs and
reduce perceived barriers of affordability are warranted. In particular,
development of programs that are affordable for small businesses is needed
(14).
The purpose of the following study was to evaluate whether a worksite
health promotion (WHP) improves health risk factors in employees and is costeffective to the employer of an organization that is small in size and is
decentralized.
Methods
For a detailed description of methods, see Chapter 1.
Cost-effectiveness ratios in the present study are presented from the
perspective of the employer and are based on data from year 1 of the
investigation. Costs are reported as direct employer costs in 2006 dollars. Costs
for the intervention include compensation for the author to present the
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educational material and administer the program, facilitation of remote site food
demonstrations and teleconferencing services (includes scheduling and
technologist support). Cost of the intervention was measured as the per-capita
cost for the intervention (I) group. Per capita costs for health screening for both
the I group and the comparison (C) group were equal and are not included in the
cost- effectiveness calculation and no costs for material development are
included. Relative percentage point reduction, in the key marker, LDL-C, was
used as the primary measure of efficacy. A secondary effectiveness outcome
measure was the absolute change in CHD risk (ACHD risk).
Computation of relative and absolute changes in LDL-C and CHD risk was
based on the calculations of Soler et al., in their 2010 review of the effectiveness
of worksite health interventions (15)(See Chapter 1).
The ten-year risk for the development of CHD was calculated using the
Framingham Risk Score (FRS) and reported as a percentage. The FRS is an
established formula that uses the measured risk factors: age, TC, HDL-C, SBP,
treatment for hypertension, and cigarette smoking and is a well-accepted tool for
health professionals (16). Risk was evaluated as follows: low risk = < 10%,
intermediate risk = > 10% and < 20%, and high risk = > 20% (17).
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Results
A detailed description of clinical results is presented in Chapter 1.
At 12 months, LDL-C was significantly less in the I group than the C group
(110.86 ± 4.4 mg/dl, 126.67 ± 4.0 mg/dl respectively, p = 0.011) and approached
significance from the baseline value (p = 0.06) a relative decrease of 13.4%.
LDL- C was not different at 12 months from baseline in the C group. TC in the I
group decreased significantly from baseline to a value that was also significantly
less than that found in the C group at 12 months (183.4 ± 4.4 mg/dl, 198.6 mg/dl,
respectively, p = 0.001 within group, 0.013 between groups). TC in the C group
was not different from baseline at the end of one year. The mean WC of the C
group increased significantly from baseline, (98.8 ±1.0 cm, p= 0.001); there was
no change from baseline in the mean WC among the I group. No other withingroup or between-group differences in weight, BMI, PCTFM, TBWPCT, SBP,
DBP, HDL-C, TC/HDL, TRG, FG or hsCRP were found.
Chi-square analysis of the FRS score of the C and I group at 12 months
(1.8 ± 0.5,1.9 ± 0.5) showed no significannt between-group or within-group
differences from baseline. However, the absolute reduction in CHD risk of the I
group was 0.3 percentage points, a relative improvement of 18% in a population
estimated to be low-risk at baseline. The results of health screening tests are
shown in Table 1.3, Chapter 1.
Direct employer cost for the Intervention was $136.27 per participant in
2006. (Table 2.1). Cost effectiveness of the Intervention was $10.17 per
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percentage point reduction in LDL-C and $454.23 per point reduction in CHD
risk. (Table 2.2).

Table 2.1 Per capita cost ($) for one year University of New Hampshire Cooperative
Extension Worksite Health Promotion for Intervention participants
INTERVENTION EDUCATION

Cost ($)*

Videoconferencingb

35.00

Wellness program managed

58.33

Remote site coordination

10.00

Pedometers

32.94

COST FOR INTERVENTION

136.27

a2006 dollars
bVideoconferencing includes scheduling and technical support
'Wellness educator (35 hrs - delivery of program, communication with participants and administration time)
Administration, food demonstrations

Table 2.2 Comparison of cost-effectiveness ratios for one year UNH Cooperative Extension
Workplace Health Promotion (WHP) with cited references
Measure of
Effectiveness

UNH WHP C-E Ratio

Reference

Reference C-E Ratio

LDL-C

$10.17 per relative %
point reduction

Economic analysis of Killilea
and Funk (18)

$12 to $19 per relative %
point reduction

$454.23 per absolute
point reduction

Intervention study by
Finkelstein, etal. (19)

$470 per absolute point
reduction

CHD Risk

C-E ratio = cost-effectiveness ratio, LDL-C = Low density lipoprotein cholesterol
CHD Risk = the ten-year risk for the development of CHD using the Framingham Risk Score (16)
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Discussion
Findings of the present study show that a worksite healthy lifestyle
program can reduce the CHD risk factor LDL-C by 13%. Substantial evidence
exists that reduction of LDL-C also reduces the risk of heart disease (6). The
calculated 1.4% CHD risk reduction per percentage point reduction in LDL-C
achieved in the present investigation is comparable to that of other studies that
identified the CHD risk-reduction benefit achieved per unit of LDL-C reduction
(20 ).

Since the consequence of the failure to prevent disease is often treatment,
economic comparisons of this study are made in relation to both pharmaceutical
and lifestyle interventions. HMG-CoA reductase inhibitor drugs (statins) have
been established as agents for preventing CHD through LDL-C reduction.
Although lifestyle interventions and pharmaceutical management of
hyperlipidemia are both utilized for the primary prevention of CHD, it is believed
that the most cost-effective means to curb CHD risk are lifestyle changes (6).
Evidence that lifestyle changes are more cost-effective than drug treatment for
LDL-C reduction is supported by the calculated C-E ratio of $10.17 per one
percent reduction in LDL-C found in the present investigation. This compares
favorably with the $12 - $19 per percent LDL-C reduction reported for statin
treatments (18).
Finklestein et al. have published results of the on-going, multi-centered,
study WISEWOMAN (21). These authors reported a C-E ratio related to changes
in CHD risk of $470 per point reduction in the ten-year CHD risk for the wellness
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intervention (19). The C-E ratio of the present study was $454.23 per point
reduction in CHD risk. Because WISEWOMAN examined the differences
between a health screening group and a screening group plus educational
intervention in CHD risk reduction, it is a suitable cost-effectiveness comparison
with the present findings. The investigators of WISEWOMAN reported that the
program is a cost-effective approach for reducing CHD risk (19). Therefore, it can
be claimed that the currently reported program is cost-effective as well.
The primary component of this intervention program was the educational
sessions delivered by videoconferencing simultaneously, to different worksites of
a decentralized organization. Delivery of the lifestyle education accounted for
most of the expense of the intervention and amounted to $103.33 per participant.
Potentially, this cost could be less per capita, since additional videoconference
attendees add no cost. Moreover, access to the video conference could be
broadened. Different types of workplaces and organizational structures may
require flexible arrangements for the delivery of wellness education, particularly if
the organization is small and decentralized. For example, live educational
sessions might be viewed on personal desktop computers at work, as the most
up-to-date software allows for remote internet viewing and archiving for later
viewing. The use of technology can help to ease concerns about high costs and
accessibility.
Limitations of the present study include the possibility that undesirable
results prompted private interventions outside of the research protocol, as all
participants were made aware of their testing results and received health
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newsletters. It was beyond the scope of the study to control for outside influences
that would modify behaviors. However, no differences were reported in the use of
prescription medications from baseline at 12 months in either group. Another
limitation was that our sample size was relatively small and not selected for the
presence or absence of pre-existing risk factors. It was the intent of the
investigation to recruit the employees of a small organization which limited the
potential subject pool. However, participation was 35% of employees; and
analysis of baseline characteristics between groups indicated no differences in
measures of CHD risk, including medication use. On the other hand, it could be
argued that the unselected subject population strengthens the impact of the
present results in that they reflect a typical employee population, which increases
the generalizability of the findings. Because specific lifestyle changes associated
with the improved LDL-C found in the I group of this study were not identified,
future studies might include design methodologies that quantify lifestyle
characteristics in a way that is standardized and comparable to other
investigations.
Conclusions
Findings of the present study demonstrate that LDL-C and overall CHD
risk can be reduced in a relatively healthy employee group following health
screening and lifestyle education. The expense of a healthy lifestyle intervention
delivered at the worksite by videoconference is cost-effective, when compared to
the pharmaceutical option of statin administration, or lifestyle education in a
clinical setting.
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A workplace health promotion program with an educational component
delivered by videoconference can be a cost-effective method of supporting
change that will translate into overall health and cost benefits for both employers
and employees. If employers and employees can successfully participate in
programs designed to improve the health of employees, at reasonable cost, both
parties will benefit.
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CHAPTER 3: DIFFERENCES IN HEALTH PERCEPTIONS AND
BEHAVIORAL CHANGES BETWEEN GROUPS PARTICIPATING IN A

WORKSITE HEALTH PROMOTION

Introduction
Preventable chronic health problems such as cardiovascular disease
(CVD), type II diabetes and metabolic syndrome are costly to society, individuals
and to employers. Workplace Health Promotions (WHPs) are known to be
effective in chronic disease risk reduction and can be implemented at reasonable
cost, benefitting both the employer and employee (1). See Chapters 1 and 2.
Cooperative Extension is the federally-mandated outreach arm of the
University of New Hampshire charged with bringing educational programs based
on current research to the public, often free of charge. As a worksite, Extension
is unique because it is decentralized, its offices spread geographically throughout
the state, and is equipped to help local communities and business invest in good
health (2). Nutrition, health care strategies, financial management, and workforce
education (including WHP) are examples of outreach programs that might be
offered by Extension (3).
Extension expertise meets public needs at the local level, and has utilized
multi-dimensional strategies for educational outreach that include the innovative
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use of technology (4). Extension professionals are both leaders and community
members and are in a position to apply multifaceted approaches in promoting
healthier lifestyles. Often the design of those programs incorporates research
from more than one academic discipline. In addition to utilizing knowledge gained
from nutrition and exercise science, healthy lifestyle promotion is guided by
research on how people think and what influences their behavior (5).
There are many theoretical models of health behavior with the common
underlying premise that several psychosocial characteristics contribute to lifestyle
behaviors. (Table 3.1). Nutrition education, as it relates to health, does not
espouse a singular health behavior change theory specific to the discipline.
Components of multiple theories have been borrowed and applied to predict
health behaviors. However, none of the current theoretical models fully predict
behavior change; and, it has been suggested that combining compatible theories
may therefore be the most effective approach in nutrition education as it relates
to health (6). A review of the literature noted that many variables are common
among key theories and that studies often use compatible variables from related
theories (7). Self-efficacy (confidence), decisional balance (importance) and
commitment are examples of variables that are measured to predict health
behavior change (8).
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Table 3.1 Health Behavior Theories Commonly Applied to Lifestyle Programs and
Research
Theoretical Model

Summary
The KAB model relies heavily on the concept that
knowledge is not only essential but provides motivation
and attitude to make positive health changes (6).

Knowledge- Attitude-Behavior (KAB)

HBM propose that health-related action is dependent on
sufficient motivation to make health relevant, the belief
that health risk is present, belief that a behavior change (if
perceived barriers can be overcome) will reduce risk, and
that the behavior change is achievable. The emphasis of
the HBM is that a perceived threat is the motivating force;
perceived benefits (less barriers) become incentives for
behavior change (9).

Health Belief Model (HBM)

TTM aka SOC originated from analysis and integration of
common processes that individuals use to make changes
in behavior. This model proposes that health behavior
change can be seen as a continuum based on an
individual's readiness to change. This change is gradual
and occurs through a series of stages: precontemplation,
contemplation, preparation, action and maintenance. TTM
suggests that self-efficacy and weighing the pros and
cons of change are important mediators of change (10).

Transtheoretical Model (TTM) /
Stages of Change (SOC)

The SCT model of health behavior change assumes that
knowledge of health risks and the related lifestyle habits
create the precondition for behavior change. The central
role of self-efficacy is considered a core determinant of
effective action. Self-efficacy in this model differs from
confidence in that it includes both an assertion of
capability to engage a behavior (“I can do this.”) and the
conviction that the behavior will occur (“I can do this and I
will do this.”). Short- term attainable goals are stressed as
tools for the incremental development of self-efficacy (11).

Social Cognitive Theory (SCT)

6.
9.
10.
11.

Achterberg C. J Nutr Educ Behav 2004;36:40-2.
Rosenstock IM. Health Educ Q 1988; 15:175-83.
Prochaska JO. Prog Clin Biol Res 1984;156:131-40.
Bandura A. Health Educ Behav 2004;31:143-64.

The aim of the present study was to evaluate whether or not there were
differences in health perceptions and lifestyle behaviors after participation in a
WHP between an intervention (I) group receiving group lifestyle education via
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interactive teleconference plus e-mailed newsletter and a comparison (C) group
receiving lifestyle education through e-mailed newsletter only.
Methods
Study participants were volunteers from the employees of UNH
Cooperative Extension. All employees were screened at baseline, 12 months and
24 months for anthropometric, clinical, dietary and biochemical risk factors for
CVD and metabolic syndrome and completed health questionnaires. In addition,
participants completed an exit survey at 24 months. All participants received hard
copies of their screening results as well as periodic newsletters related to healthy
lifestyles via email. The primary component of the intervention was educational
sessions that were interactive and delivered simultaneously across the state by
videoconference technology. The I group also received pedometers and
instructions to report the number of steps taken weekly. The principal sources of
data used to determine the health perceptions and behaviors of the participants
were a Health Questionnaire at baseline, 12 and 24 months, along with an Exit
Survey at 24 months. Differences in health perceptions and behaviors were
measured using the following variables: Importance, Readiness to Change,
Confidence, Commitment and Barriers. (Table 3.2). These data were examined
separately, and in some cases, analyzed relative to clinical outcomes such as
waist circumference (WC). Interpretation of open-ended responses was tested
for agreement among three raters using an online calculator developed
specifically for use when multiple raters are not restricted in the number of codes
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that are assigned to a singular response. The free-marginal kappa (Kfree) of 0.70
or above indicates adequate interrater agreement (12). (Table 3.3).

Table 3.2 UNHCE Workplace Health Promotion
Health Behavior and Perception Questionnaire Variables

D efinition aiven to oarticiDants: Lifestyle chanaes are chanaes to improve vour health, such as adiustina vour diet,
increasing your physical activity, and changing health-related behaviors.

Variable

Assessm ent Question

1.

Importance

Put an X on the line below to show, on a scale from 0 to 10, how important it is for you
to make lifestyle changes. (0 Not very important, 5 Somewhat important, 10 Very
important)

2.

Readiness to
change

Put an X on the line to show how ready you are right now, on a scale of 0 to 10, to make
lifestyle changes. (0 Not very ready, 5 Somewhat ready, 10 Very ready)

3.

Confidence

Put an X on the line to show how confident you are, on a scale of 0 to 10, that you can
make lifestyle changes. (0 Not very confident, 5 Somewhat confident, 10 Very confident)

4.

Commitment

What lifestyle changes would you be willing to make?

5.

Barriers

What things might make it hard for you to make lifestyle changes?

Variables 1 - 3 were quantitative questions and answered on a scale of 0 - 1 0 . Variables 4 and 5 were open-ended
questions and analyzed according to category code of each response as well as by frequency counts; i.e., number of
lifestyle change and number of barriers perceived.

Detailed descriptions of the Questionnaire, Exit Survey methods, teleconference
educational sessions and statistical treatment of data can be found in Chapter 1
and the Appendix . Newsletters can be viewed on the enclosed CD.

65

Table 3.3 Interater Agreement (Kfree)(13) for Open-ended Responses from UNHCE Workplace Health
Promotion Exit Survey and Health Questionnaire

Kfree1

1.

Questionnaire Commitment and Barriers Questions

0.82

What lifestyle changes would you be willing to make?

0.78

What things might make it hard for you to make lifestyle changes?

0.76

As a result of participating in the UNHCE Workplace Wellness program: What lifestyle changes (for example,
healthy diet and activity choices, health maintenance and stress management) have you made? Please be
specific.

0.83

As a result of participating in the UNHCE Workplace Wellness program: What health changes have you
made? Please be specific.

0.68

Should UNHCE have a Workplace Wellness Program? Why or why not?

0.33

Please comment on the UNHCE Workplace Wellness program (what did you like; what did you dislike; do you
have any suggestions for changes?

Values of kappa can range from -1.0 to 1.0, with -1.0 indicating perfect disagreement below chance, 0.0
indicating agreement equal to chance, and 1.0 indicating perfect agreement above chance. A rule of thumb is
that a kappa of .70 or above indicates adequate interrater agreement.(12)

Results
Major clinical and dietary outcomes
At year one from baseline, WC and Mets markers (MetS) increased
statistically in the C group; Total (TC) and LDL-cholesterol (LDL-C) decreased in
the I group. The I group consumed a lower ratio of dietary omega-6 to omega-3
fatty acids than reported by the C group at 12 months. Additionally, the I group
decreased their intake of unspecified fats from baseline, a group of dietary fats
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that includes trans fats. The I group participants also increased the average
steps taken per day and maintained the level throughout the year. In year two,
the changes in TC, LDL-C and MetS were sustained. A decrease in WC in the I
group resulted in a significant difference from that of the C group at 24 months.
Complete results of anthropometric, clinical, dietary and biochemical tests
are found in Chapter 1.
Health Questionnaire
At baseline, 18 of 31 C group (58.1%) and 20 of 29 I group (69%)
completed questionnaires. At 12 months, questionnaires were completed by 16
of 29 C group (55%) and 14 of 26 I group (53%). At 24 months, 19 of 23 C group
(78.3%) and 17 of 20 I group (85%) returned questionnaires. Seventy percent of
the participants from each group who completed the entire 24 months of the
WHP returned all three questionnaires, (16 of 23 C group, 14 of 20 I group).
No differences were seen between groups, at baseline, 12 months or 24
months in responses related to frequency of medical check-ups, out-of-pocket
medical expenses, sick-day absences, medication use and consumption of
dietary supplements.
Importance, readiness to change, confidence, and stress levels. There
were no differences between or within groups found in the scaled responses (0 10) to queries of how important it is to make lifestyle changes, readiness to make
lifestyle changes, confidence in ability to make changes or in level of stress in
year one or in year two. (Table 3.4).
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Table 3.4 Scaled Measures of Importance, Readiness to Change, Confidence and Stress

Year 1
Comparison

Year 2
Intervention

Comparison

Intervention

Variable

Baseline

12 mos

Baseline

12 mos

12 mos

24 mos

(0 - 1 0 )

(n = 24)

(n =16)

(n = 23)

(n = 17)

(n = 19)

( n = 12)

Importance

8 .0 ± 0.3

8.0 ± 0.3

8.0 ± 0.3

8.2 ± 0.3

8.5 ± 0.6

7.7 ± 0.6

8.6 ± 0.7

7.7 ± 0.7

Readiness to
change

7.5 ± 0.3

7.9 ± 0.4

7.6 ± 0.4

7.0 ± 0.4

8.3 ± 0 .6

7.6 ± 0.7

8.6 ± 0.7

8.4 ± 0 .7

Confidence

6.7 ± 0.4

6.6 ± 0.4

6.8 ± 0.4

6.6 ± 0.4

7.6 ± 0.7

7.7 ± 0.8

8.1 ± 0.8

8.5 ± 0.8

Stress level

5.6 ± 0.4

5.4 ± 0.5

5.6 ± 0.5

5.0 ± 0.6

5.3 ± 0.8

5.3 ± 0.8

5.4 ± 0.8

5.0 ± 0.9

12 mos
( n = 18)

24 mos
(n = 12)

Least square means of quantitative Questionnaire variables in year 1 and year 2. General linear model performed
using age and gender as covariates and post-hoc analyses were conducted using Tukey’s Honestly Significant
Difference test. The level of statistical significance was set at p < 0.05. Between group and within group analyses are
all NS. Data are presented as LSM ± SE on a scale from 0 - 1 0 .

Commitment and Barriers. In response to the question “ What lifestyle
changes are you willing to make”, no statistical differences in the in the number
of lifestyle changes that participants would be willing to make were reported
between groups or within groups during year one. At 24 months, the I group
reported they were willing to make significantly more lifestyle changes than at 12
months (2.47± 0.2, 1.98 ± 0.2 respectively, p = 0.04) which was also more than
the C group reported at 24 months (1.75 ± 0.2, p = 0.002). Chi square analysis of
the individual response categories (none, consume healthier diet, increase or
maintain exercise, both healthier diet and exercise) for this question at baseline,
12 month and 24 months showed no statistical differences between groups.
In response to the question “ What things might make it hard for you to
make lifestyle changes”, no significant differences in the number of barriers to

68

making lifestyle changes were identified between or within groups. However, the
number of barriers reported by the I group at 12 months (1.84 ± 0.2) trended
higher than at baseline (p = 0.07), and higher than reported by the C group (p =
0.08) at 12 months. There were no differences seen in either group in year 2 or
between groups at 24 months. Chi square analysis of the individual response
categories (none, time conflicts, family, stress/illness) for this question at
baseline, 12 months, and 24 months was not different between groups. The most
frequent response given by both groups was “time conflicts” (C group 67%, I
group 64%).
In response to the question “Has participation in UNH Cooperative
Extension Workplace Wellness Study impacted your lifestyle (diet and activity
choices, health maintenance and stress management)”, more I than C group
reported “improved” (83% vs. 58 %), a differences that approached significance
at p = 0.09. Significantly fewer I group than C group participants (11 % vs. 42 %,
p = 0.034) reported “no change”. Only one participant ( I group) reported
“worsened”, which was not significant between groups.
In response to the question “Has participation in UNH Cooperative
Extension Workplace Wellness Study impacted your health”, no differences
between groups were found. “Stayed the same” was the response of 37% of C
and 33% of the I groups while “Improved” was reported by 58% of the C and 67%
of the I groups. Only one respondent reported “Worsened” (I group) and this was
not significantly different from C group.
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In response to the question “Has participation in UNH Cooperative
Extension Workplace Wellness Study impacted how you feel”, no differences
between groups were found. “Stayed the same” was the response of 42% of C
and 36% of the I group participants while “Improved” was reported by 58% of the
C and 64% of the I group. No respondent reported “Worsened”.
Exit Survey
Exit Surveys at 24 months were completed by 17 of the 23 C participants
(74%) and 18 of the 20 I participants (90%).
In response to the Exit question “As a result of participating in the UNHCE
Workplace Wellness program: What lifestyle changes (for example, healthy diet
and activity choices, health maintenance and stress management) have you
made? Please be specific.”, significantly more of the I group than the C group
participants reported increased physical activity (84.2% vs. 41.2 % , p = 0.007)
and improved diet (63.2% vs. 29,4 %, p = 0.043). One-third of the I group
reported increased health awareness (for example, “ increased awareness of
healthy diet or increased awareness of need for physical activity”) while no C
group participants gave a similar response (33.3% vs. 0%, p = 0.17). Twenty-four
percent of the C group reported making no specific lifestyle changes compared to
zero percent of the I group giving this response (p = 0.025).
In response to the Exit question “As a result of participating in the UNHCE
Workplace Wellness program: What health changes have you made? Please be
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specific.”, fifty percent of the C group reported making no specific health changes
at all, compared to 16.7% of the I group (p = 0.04). (Figure 3.1 A)
Figure 3.1 A. Lifestyle and Health Behavior Changes Reported in Exit Survey

Lifestyle and Health Changes
N o sp ecific h e a lth changes
N o specific life s ty le changes

Im p ro v e d d ie t

■ In te r v e n tio n

In c re as e d exercise
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Percent o f Group Responses

p = < 0.05

Significant differences between groups in response to Exit Questions regarding lifestyle and health changes made as a
result of participation in the UNH Cooperative Extension Workplace Health Promotion. Pearson’s Chi square analysis
was used to examine category responses between groups. Data are presented as the percent of all responses within
each group. The level of statistical significance was set at p < 0.05.

In response to the Exit question “Should UNHCE have a Workplace
Wellness Program? Why or why not”, there were no differences between groups.
Both groups gave a strongly positive response to the query (C group 83.3% vs. I
group 88.9%). Two respondents in each group responded “maybe”, and the
single negative response was given by a C group participant. (Figure 3.1B).The
most frequent reasons given were “positive impact on health” (C group 83.3%, I
group 88.9%) and “positive effect on work environment” (C group 27.8%, I group
38.9%).
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Figure 3.1 B Participants’ Support for a Workplace Health Promotion
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Responses to Exit Question “Should UNHCE have a Workplace Wellness Program”. Pearson’s Chi square analysis
was used to examine category responses between groups. Data are presented as the percent of all responses within
each group. The level of statistical significance was set at p < 0.05. All categories are NS.

In response to the Exit question “Please comment on the UNHCE
Workplace Wellness program (what did you like; what did you dislike; do you
have any suggestions for changes”, unfavorable comments were more likely to
be made by C group participants than I group participants (50% vs. 5.5 %. p =
0.024) and favorable comments were more likely to be given by I group
participants, although the large majority of subjects from both groups made at
least one favorable remark (100%, I group vs. 75%, C group. P= 0.003). There
were no strictly unfavorable comments. Many responses listed satisfaction with
most or some of the program protocol and added what was disliked, for example,
“I liked the monthly meetings and the information that was given. I didn't like
keeping track of our activity.” The I group was more likely to report liking some
aspect of the study protocol (for instance, “Screenings were helpful with
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immediate feedback” or “I liked the newsletters”) than the C group (83.3% vs. 50
%, p = 0.038), while the C group was more likely to report disliking some clinical
aspect such as “fingerstick” or “fasting” of the study protocol (50% vs. 11.1%, p =
0.013).
Correlations between clinical variables and questionnaire responses
Multiple regression analyses were used to determine if any of the behavior
variables during the intervention year one could explain changes in waist
circumference or the number of lifestyle changes reported.
Regression analysis, using WC at 12 months as the dependent variable,
showed that 68% of the variance of all participants could be predicted by three
variables: CRP at 12 months (r = 0.53, p <0.001), intake of dietary unspecified
fats at 12 months (r = -0.205, p = 0.1) and the reported confidence in one’s ability
to make changes as reported at baseline (r = -0.49, p = 0.001). Regression
analysis using the number of specific lifestyle changes reported by participants in
the exit survey as the dependent variable showed that 15% of the variation found
could be predicted by the reported confidence in ability to make changes at 24
months (r= 0.0.39, p = 0.027).
Separate regression analyses were done for the C and I group data using WC at
12 months as the dependent variable; independent variables were CRP at 12
months, and these variables: importance of changing at 12 months, readiness to
change at 12 months, and confidence at 12 months. In all cases, CRP was
strongly and significantly correlated with WC at 12 months. In the C group,
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importance (r = -0.5, p = 0.002) and readiness to change (r = -0.40, p = 0.02)
were significantly correlated to WC; confidence (r = -0.34, p = 0.06) was nearly
significantly negatively correlated with WC at12 months. In the I group, none of
the three additional variables were significantly correlated with WC at 12 months.
(Table 3.5). Additional regression analyses of data from each treatment group
using WC at 24 months as the dependent variable, CRP at 24 months and
confidence at 24 months as the independent variables were done. In both
groups, confidence at 24 months was inversely related to WC at 24 months, but
was only significant in the I group, and trending toward significance in the C
group.
Discussion
Relationship of health perceptions and behaviors to intervention and
clinical outcomes
The present study indicated that health perceptions and behaviors of participants
in a WHP designed to reduce CVD risk were dissimilar between a comparison
group receiving only minimal information in the form of e-mailed newsletters and
an intervention group that also participated in a series of interactive educational
sessions delivered by videoconference. We were able to identify an association
of health perception variables with the clinical risk factor of waist circumference,
as well as with a measure of behavior change (number of lifestyle changes
made). In addition, the measure for commitment to change in the I group
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Table 3.5 Regression Analyses Performed Separately by Treatment Group Using Waist
Circumference at 12 Months as Dependent Variable

Comparison

h-

II
Z

R2 = 0.76

R2 = 0.5

II

Intervention

Independent Variable

Std Coefficient

Independent Variable

Std Coefficient

Constant

0

<0.00

Constant

CRP (12 mo)

0.7

<0.00

Importance (12 mo)

-0.50

P

0.002

P

0

0.005

CRP (12 mo)

0.65

0.004

Importance (12 mo)

0.27

0.17

R2 = 0.39

N = 18

Independent Variable

Std Coefficient

R2 = 0.67

N = 17

Independent Variable

Std Coefficient

Constant

0

<0.001

Constant

0

<0.001

CRP (12 m)

0.71

<0.001

CRP (12 mo)

0.59

0.01

Ready to Chg (12 mo)

-0.40

0.02

Ready to Chg (12 mo)

0.2

0.34

P

R2 = 0.43

N = 18

Independent Variable

Std Coefficient

P

R2 = 0.62

N = 17

Independent Variable

Std Coefficient

Constant

0

<0.001

Constant

0

<0.001

CRP (12 mo)

0.71

0.001

CRP (12 mo)

0.66

0.004

Confidence (12 mo)

-0.34

0.06

Confidence (12 mo)

0.054

0.79

P

P

Separate regression analyses of Comparison and Intervention groups using waist circumference at 12 months as the
dependent variable. CRP, importance, readiness to change and confidence were used as independent variables. The
level of statistical significance was set at p < 0.05.

increased during the study and was greater than in the C group at 24 months.
Intervention group participants reported increases in physical activity and
improved diet, as well as greater health awareness as a result of study
participation.
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Behavior change that results in a healthier lifestyle is likely to result in a
physiologic shift toward wellness that can be measured. We found an association
between confidence in the ability to make changes and waist circumference, an
important risk factor for CVD, type II diabetes and metabolic syndrome.
Individuals within the entire cohort who had lower confidence levels at baseline,
were less likely to maintain or reduce their waist circumference over the first year
of the study; this effect remained for the C group but not the I group, when the
treatment groups were analyzed independently. It is noteworthy that, in the I
group, WC at 12 months correlated positively with the response to importance of
change queried at baseline. It did not correlate however, with other baseline
variables of perception. The positive relationship between clinical measures and
perceived importance may indicate that individuals in the I group with a larger
WC entered the study with a greater sense of need for change than others, even
though at baseline, the WC of the groups was not found to be different. Waist
circumference increased significantly in the C group at 12 months, but not in the I
group.
The greatest difference, and probably the most relevant, related to health
perceptions between groups was seen at 12 months. In the I group at 12 months,
WC did not correlate with the variables of perception (importance, readiness to
change, or confidence). This differs from findings of the C group in that WC at 12
months was associated negatively with “importance” and “readiness to change”;
in addition, there was a negative trend with “confidence”.
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Our findings are similar to those of Hankonen et al., who compared the
effect of personality with health-related self-efficacy on the change in WC over 12
months. They found self-efficacy to be positively related to WC reduction
following group lifestyle intervention. They also noted that baseline self-efficacy
had no effect on waist circumference change at 12 months (14). What this
suggests is that the level of self-efficacy before a start to make lifestyle changes
may not predict those who will be successful in their attempt; and reinforces the
notion that self-efficacy is modifiable and a practical target for intervention
programs.
The results of the relationship of “importance” to WC in the I group
between baseline and 12 months were somewhat inconsistent. These findings
may support the assertion that behavior change had occurred during the year in
the I group; therefore reducing the importance of making further change.
Confidence in the ability to make changes had a positive association with
the number of lifestyle changes made during the 24 months by the present study
in the entire cohort, and was independent of treatment group. This would seem to
be the case regardless of the mode of information received by the participants.
These findings suggest that individuals of both treatment groups, who had
showed greater confidence in their ability to make lifestyle changes, at 24
months, also reported making more lifestyle changes. We did not find an
association between the perception of importance of change, or the readiness to
change with the number of lifestyle changes made.
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Commitment, measured in the present study by the number of lifestyle
changes participants were willing to make, did increase significantly in the I group
by 24 months, but not in the C group. Additionally, the I group reported making
more lifestyle changes than the C group; and more of the I than C group
participants claimed to have an improved lifestyle as a result of study
participation. These results are somewhat consistent with those of a crosssectional study done by Kelly to determine the predictive ability of behavioral
variables on changes in diet. In that study, neither confidence nor importance
was a significant predictor of change. However in that study, commitment to
change was found to be the most influential and the most predictive variable of
stage of change. Commitment values increased with each progressive stage of
change, being strongest in the Action and Maintenance stages (8). We could
assert that the evidence of increased commitment along with increased number
of lifestyle changes made in the present study indicate a transition to an action
stage in our intervention group.
Taken together with the findings of the Kelly study, this suggests that the I
group transitioned through the stages of change resulting in behavior changes
that were not observed or reported in the C group. Further evidence in support of
that interpretation was found in our study at 12 months, when the I group
identified more barriers to making lifestyle changes than at baseline, and when
compared to the C group at 12 months. Contento maintains that both selfefficacy and decisional balance (importance) may change over a course of action
as the new behavior may turn out to be more difficult than originally perceived
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(15). It stands to reason that individuals who made efforts towards meaningful
change would encounter some unforeseen barriers to adopting a new behavior,
and therefore, improve self-efficacy as the change becomes habit, a process that
was not expected for the C group. The periodic education over 24 months may
have provided the I participants with more lifestyle success “tools” over time,
allowing for repeated mastery of the new behavior, and thus, increased selfefficacy.
Videoconference as an effective health promotion tool
The use of technology facilitated the WHP intervention of this study in a
statewide decentralized worksite, although technology use for such programs is
not novel. Distance education for workers delivered online or by
videoconference, has been found to be efficacious and economical (1, 16) and
educators have found interactive distance learning to be as effective a learning
environment as traditional face-to-face methods (17).
In the present study, the simultaneous delivery of educational information
and interactive component of the intervention was made possible by the use of
an existing videoconferencing network. Ricketts and colleagues used a similar
network to compare the efficacy of nutrition education via a videoconferencing
network with the same curricula also delivered in traditional face-to-face
instruction to health educators. The technology-based distance format was found
to be equivalent to the traditional method in attendee satisfaction and learning
(18). Employee acceptance of the presently investigated WHP was high. The
participants in both treatment groups expressed strongly positive sentiments on
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the value of a WHP, emphasizing positive impacts on health and work
environment.
We did not test for learning outcomes in this study and cannot comment
on the degree of learning differences, if any, between the treatment groups.
However, both changes in the clinical variables and reported lifestyle
modifications suggested that increasing awareness of a connection between
lifestyle behaviors and health and wellness translated into perceptual and
behavioral differences between groups, resulting in measurable clinical
differences.
Since the face-to-face (albeit distant) education sessions on changes in
lifestyle were the primary intervention between the treatment groups, it could be
argued that videoconferencing is an effective means of facilitating health
promotion that is associated with improvement in health risk factors, mediated by
positive lifestyle changes and perceptions of health.
UNH Cooperative Extension WHP as an internal and external model
The usefulness of the present study of Cooperative Extension employees
goes beyond the positive effects on health that occurred among participants. As
an outreach organization, Extension has the opportunity to partner with
employers in the community to provide or support efforts to engage in a WHP. A
study of an external WHP facilitated by Extension personnel found that
participants reduced body weight, WC, increased exercise, and improved their
readiness to increase exercise and eat more fruits and vegetables (2).
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Furthermore, Extension has provided valuable insight and experience in guiding
the development of a WHP at the University of Vermont, based on their own
employee wellness program (19).
A recent recommendation for Extension programs related to providing
assistance for worksite wellness initiatives is “Practice what you preach”.
Extension will increase its credibility as a community partner if there are similar
internal efforts to support their own employees through policies or education (2).
Strengths and limitations
One of the strengths of this study was the 12 month initial intervention
phase, followed by a less intense maintenance period of 12 months. Many
studies of WHPs or of health behavior models examine changes that occur over
a shorter period of time. We are able to assert that our findings occurred over
time and were sustained for a longer term. However, there was attrition in our
relatively small participant population, resulting in decreased statistical sensitivity
throughout the 24 month period.
A limitation of our study was the fact that many of our results are taken
from self-reported data and may suffer from bias or respondent burden overtime.
It is possible that our lower response rates, in particular at 12 months, resulted in
a loss of statistical power to measure statistically significant changes. Another
limitation was related to the instruments used to collect descriptive and
perceptual data as these were designed to be used for clinical rather than
research purposes. Future studies that include measures of psychosocial
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influence on behavior change should consider using existing validated
instruments designed for that purpose. However, the primary outcomes of this
study were the measured clinical data that were collected by the researcher, and
the secondary outcomes collected by survey or questionnaire were used to
support those clinical outcomes.
Conclusions
Findings of the present study demonstrate that a lifestyle education
component of a worksite health promotion delivered by videoconference
(intervention) can be more effective than education by newsletter alone
(comparison treatment). Employees who received education by videoconference
improved clinical measures in their total cholesterol, LDL-cholesterol, waist
circumference, markers of metabolic syndrome and they reported both increased
physical activity and improved diets. The perception of improved lifestyle, even in
the presence of barriers, was present in the intervention employees. On the other
hand, perceptions of importance of lifestyle change, readiness to change, and
confidence in the ability to change, were negatively associated with the health
risk factor of waist circumference in the comparison group only. The WHP
intervention likely resulted in increased knowledge and heightened health
awareness that translated into behavior change and resulted in improved health
in the intervention group.
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B. Informed Consent Form
Cooperative Extension Informed Consent Information
Purpose

T h e p u rp o s e o f th is re s e a rc h p ro je c t is t o g a th e r d a ta fro m a w o rk p la c e w ellness p r o g r a m a t C o o p e ra tiv e
E xtensio n.

Description of General Health Screening
Health Questionnaire and Dietary Intake - A th r e e d a y d ie t a r y re c o rd w ill be a n a ly z e d fo r n u t r ie n t in ta k e
a n d b a la n c e o f n u trie n ts in d ie t a n d a h e a lth q u e s tio n n a ire fille d o u t.

Metabolic Screening - A s m a ll b lo o d

s a m p le (fin g e r stick) w ill be t a k e n to m e a s u re b lo o d levels o f fa s tin g s u g a r, fats, a n d c h o le s te ro l a lo n g
w ith b lo o d p re s s u re a n d w a is t c irc u m fe re n c e .

Pulmonary Function Test - Forced e x p ir a to r y a ir f lo w in

o n e second and P eak E x p ira to ry F lo w w ill b e m e a s u re d u sing h a n d h e ld flo w m e te rs .

Body Composition -

Analysis o f to t a l b o d y f a t w e ig h t an d fa t f r e e w e ig h t (m u s c le a n d b o n e ) w ill be d o n e b y b io e le c tric
im p e d a n c e , a th r e e m in u te te s t using p ain le ss e le c tro d e s o n t h e h a n d a n d foo t s im ila r t o th o s e o f a n EKG.
All tes ts w ill b e d o n e tw ic e , a t t h e s ta r t a n d a ft e r tw e lv e m o n th s , e x c e p t f o r m e ta b o lic s c re e n in g , a n d
p u lm o n a ry fu n c tio n w h ic h w ill b e m e a s u re d a t th e s ta r t, 6 a n d 12 m o n th s later. S o m e e m p lo y e e s w ill
re c e iv e p rin te d e d u c a tio n a l m a te ria ls o n ly a n d s o m e e m p lo y e e s w ill also p a rtic ip a te in a n e d u c a tio n
p ro g ra m a n d t h e ir physical a c tiv ity m o n ito re d w e e k ly using p e d o m e te r s . Em plo yees in th is g ro u p w ill
in te ra c t w ith th e p ro g ra m le a d e r and a tte n d m o n th ly lu n c h tim e m e e tin g s . The g ro u p s w ill b e c o m p a r e d
t o d e te rm in e e ffe c tiv e n e s s .

Benefits and Risks

T h e g e n e ra l h e a lth s c re e n in g h as th e p o te n tia l to h e lp e ach e m p lo y e e id e n tify s tre n g th s a n d w e a k n e s s in
life s ty les a n d d ie ta ry h a b its t h a t can b e m o d ifie d re g a rd le s s o f th e g ro u p ass ig n m e n t. P a rtic ip a n ts w ill b e
g iven resu lts fro m c h o le s te ro l, trig ly c e rid e , g lu c o s e , b lo o d p re s s u re , b o d y c o m p o s itio n a n d p u lm o n a r y
te s ts . A lth o u g h th e s e re s u lts a re n o t d ia g n o s tic , t h e y c ou ld b e b ro u g h t t o a physician f o r f u r t h e r
e v a lu a tio n if a p a rtic ip a n t so w is h e d . T e s tin g a n d in fo rm a tio n p ro v id e d w ill be f r e e t o p a rtic ip a n ts . P e a k
f lo w m e te rs w ill b e f r e e to p a rtic ip a n ts . T h e r e a re f e w risk a s s o c ia te d w ith the fin g e r s tick p ro c e d u r e . V e r y
ra re ly , dizziness o r lig h t-h e a d e d n e s s o ccurs, w h ic h can q u ic k ly be a tt e n d e d to by t r a in e d s ta ff.

Confidentiality

Every e ffo rt w ill b e m a d e to e n s u re c o n fid e n tia lity . T e s t re s u lts w ill b e c o d e d and n o t d ir e c tly a s s o c ia te d
w ith y o u r n a m e a n d w ill b e u sed fo r d a ta m a n a g e m e n t o n ly .
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Consent Form for Participants in Cooperative Extension
Workplace Wellness Program

I, ____________________________________________ (print name) have been informed and
understand that the information provided in the health questionnaire, three-day dietary record
and test results of body composition, measurements of blood pressure, glucose, cholesterol,
triglycerides and pulmonary function will be used for research purposes.
I have been informed and understand that my participation in the research is voluntary. I have
been informed and understand that in reporting any information obtained in this program for
research purposes, the protection of my identity will be maintained.
I have been informed and understand that the values obtained by the above tests are not
diagnostic. If a question arises regarding these results, I understand that I may take them to my
health care practitioner for further evaluation.
I have been informed and understand that if I have any questions or concerns about the use of
my personal information, I should contact: Anthony R. Tagliaferro, Director- Center for Health
Enhancement, Dept.of Animal and Nutritional Sciences, 518 Kendall Hall, 603- 862-1726. or
anthonyt@cisunix.unh.edu.

I have been informed and understand that if I have any questions about my rights as a research
subject, I can contact Ms. Julie Simpson in the UNH Office of Sponsored Research at 603-8622003, or Julie.simpson@unh.edu to discuss them.

I agree to participate_____________________________________________

name/date.

Print Name____________________________________________________________
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Additional Clinical Results Not Shown

C.1 Year 1 MyPyramid Analysis
Comparison
Variable

Baseline
(n = 1 2 )

I 12 Months
I (n = 13 )

9.1 ± 2 .6

Intervention
Baseline

12 Months

5.2 ± 2.6

(n = 10)
7.1 ±3.3

(n = 1 1 )
4.1 ± 3 .3

1.5 ± 0 .3

1.7 ± 0 .3

1.8 ±0.4

2.4 ± 0 .4

1.2 ± 0 .2

1.2 ± 0 .2

1.4 ±0.3

1.5 ± 0 .3

1.8 ± 0 .3

1.8 ± 0 .3

1.6 ±0.4

1.4 ± 0 .4

7.3 ±1.2

6.1 ±1.1

9.4 ±1.5

8.4 ±1.5

575.7 ± 86.2

420.4 ± 87.3

493.7 ±94.8

441.3 ±96.2

88.1 ±12.8

96.6 ±12.8

99.8 ±16.4

53.8 ±16.6*

44.4 ±11.8

57.7 ±11.6

58.5 ±14.9

82.9 ±14.8

63.8 ±13.0

65.9 ±13.0

69.1 ±16.1

77.4 ±16.3

58.5 ± 9.9

60.2 ± 9.8

54.1 ±12.6

47.2 ±12.5

Meat and Beans (% of
recommended)

114.5 ±21.0

95.6 ± 20.8

152.4 ±26.6

135.3 ± 2 6.5

Discretionary calories (% of
recommended)

176.0 ±26.2

168.3 ± 2 6 .4

152.6 ±32.1

141.6 ±32.5

Grains (servings)
Vegetables (servings)
Fruit (servings)
Milk (servings)
Meat and Beans (servings)
Discretionary calories (Kcalories)
Grains (% of recommended)
Vegetables (% of recommended)
Fruit (% of recommended)
Milk (% of recommended)

* p < 0.05 within group.
Analysis of a subset of diet records returned by the same participants that completed records at both baseline and 12
months. Food-group analysis was based on the portion sizes and categories of the former U.S. Department of
Agriculture Center for Nutrition Policy & Promotion MyPyramid (www.MyPyramid.gov).
Analysis was performed using Diet Analysis Plus 8.0 using 3-day self-reported diet record. All variables corrected for
age and sex. Statistical analyses were performed by general linear model using SYSTAT 12. Post hoc analysis was
performed using Tukey's Honestly-Significant-Difference Test. Statistical significance was set at p < .05.
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D. 2 Pulmonary Measures Using Peak Flow Meters
Comparison
Variable

Intervention

Baseline

12 months

24 months

Baseline

12 months

24 months

n=21

n=4

n=8

n=20

n=4

n=9

PEF % Pred

78.8 ± 1.1

81.0 ±2.1

77.3 ± 1.5

79.1 ± 1.0

81.7 ± 1.9

81.3 ± 1.3

PEF avA per day( L/min)

36.5 ± 6.3

21.7 ± 9 .9

24.0 ± 7.6

32.0 ± 6.2

20.2 ± 9.6

35.6 ± 7.3

FEV1 % Pred

96.0 ± 1.8

96.3± 3.4

88.8 ± 2.6

97.3 ± 1.7

100.4 ± 3.1

99.1 ± 2.2A

FEV1 avA per day (L)

0.3 ± 0.1

0.3 ± 0 .1

0.2 ± 0.1

0.3 ± 0.1

0.4 ± 0.1

0 .3 ± 0.1

p < 0.05 between groups. Data are presented as LSM ± SE. Statistical analysis performed by General Linear Model
using SYSTAT 12. Post hoc analysis was performed using Tukey’s Honestly-Significant-Difference Test. Statistical
significance was set at p < 0.05.
FEV1 - forced expiratory volume (L) in 1 second, PEF - Peak expiratory flow rate (L/min)
% PRED FEV1, % PRED PEF - Test values were compared to predicted normal values for PEF (Nunn AJ, Gregg I.
Bmj 1989;298:1068-70.) and FEVi (Crapo RO, Morris AH, Gardner RM. Am Rev Respir Dis 1981;123:659-64.);
Percent of predicted = (measured PEF or F E V i) / (predicted PEF or FEVi) * 100
PEF avA per day and FEV1 avA per day = absolute difference between morning and evening measures of PEF and
FEV1.

C. 3 Average Reported Steps per Day by Quarter Year
Year 1 and Year 2 in Intervention Group
n

Quarter

Steps/Day

P

Y e a rl
20

Baseline

5253 ± 368

20

1

6465 ± 368

0.15

17

2

71 4 9 ± 400

0.01

14

3

6890 ± 440

0.04

13

4

6878 ± 456

0.05

Year 2
14

Baseline

70 1 0 ± 367

14

5

6426 ± 367

0.79

9

6

6787 ± 458

1.00

7

7

6168 ± 518

0.68

4
6251 ± 705
8
0.88
Data are presented as LSM ± SE. Statistical analysis performed by General Linear Model using SYSTAT 12. Post hoc
analysis was performed using Tukey’s Honestly-Significant-Difference Test. Statistical significance was set at p < 0.05;
p values represent differences from annual baselines.
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E. Survey Instruments with Additional Results
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D .l Workplace Wellness Program Health Questionnaire

A.

Descriptive questions

1.

M ed ical H isto ry

Condition

Yes

No

A s th m a

H igh b lo o d p re s s u re

H y p e rlip id e m ia

C a rd io v a s c u la r d isease

T y p e 2 d ia b e te s

M e ta b o lic s y n d ro m e

2.

M edications (in clu d e o ra l contraceptives):

L is t :

3.

Do you take any v ita m in , m in e ra l, h e rb a l o r o th e r d ie ta ry supplem ents ( fo r e x a m p le
p ro te in pow ders)?

a No
0Yes List:
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B.
4.

Q u a n titativ e questions
D u ring th e past year, ho w m any days d id illness o r p o o r h e a lth keep you fro m

w o rk ?

_________ N u m b e r o f days

_________ N o n e

_________ D o n 't k n o w

_________ I p r e fe r to g iv e n o a n s w e r.

5.

H ow long has it been since you last visited a h e a lth care p ra c titio n e r fo r a check up?
_________ W ith in t h e past y e a r

_________ W ith in t h e p ast fiv e y e a rs

_________ D o n 't k n o w

_________ N e v e r

_________ I p r e fe r t o g ive no a n s w e r.

6.

W h a t a re y o u r a p p ro x im a te a n n u a l o u t-o f-p o cket m ed ical costs?
_________ N o n e

_________ $0 - $ 5 0 0

_________ $ 5 0 0 - $ 1 0 0 0

_________ M o r e th a n $ 1 0 0 0

_________ D o n 't k n o w

_________I p r e fe r t o g ive n o a n s w e r.

7.

Do you sm oke cigarettes?

0 Yes - H o w m a n y in a ty p ic a l d a y ? __________________________
S No
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8.

Put an X on the lin e b elow to show, on a scale fro m 0 to 10, h o w im p o rta n t i t is fo r
you to make lifestyle changes? (Lifestyle changes are changes to improve your
health, such as adjusting your diet, increasing your physical activity, and changing
health-related behaviors.)

10

Not very important

9.

Somewhat important

Very important

P ut an X on the lin e to show h o w re a d y you a re r ig h t now, on a scale o f 0 to 1 0, to m a k e
lifestyle changes.

10

Not very ready

10.

Somewhat ready

Very ready

P ut an X on the lin e to show h o w c o n fid en t you are, on a scale o f 0 to 10, th a t you can m a k e
lifestyle changes?

10

Not very confident
11.

Somewhat confident

Very confident

P u t an X on the lin e to show y o u r c u rre n t le v e l o f stress, on a scale o f 1 to S.
0

Very relaxed

5

Managing OK
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10

Very stressed

C. Qualitative Questions
12.

W h a t lifestyle changes w o u ld you be w illin g to m ake?

13.

W h a t things m ig h t m ake i t h ard fo r you to m a ke life s ty le changes?

D. Participation Questions (at 24 months only)

14.

Has p a rtic ip a tio n in UNH C ooperative Extension W o rk p la c e W ellness Study im p a cted y o u r
lifestyle (d ie t a n d a ctiv ity choices, h ea lth m ain ten an ce and stress m an ag em en t)?

a.
b.
c.
d.
e.
f.
g.
h.
15.

Stayed the same
Improved a little
Improved somewhat
Improved a lot
Worsened a little
Worsened somewhat
Worsened a lot
Choose not to answer

Has p a rtic ip a tio n in UNH C ooperative Extension W o rk p la c e W ellness S tudy im p a c te d y o u r

health ?
a.
b.
c.
d.
e.
f.
g.
h.

Stayed the same
Improved a little
Improved somewhat
Improved a lot
Worsened a little
Worsened somewhat
Worsened a lot
Choose not to answer
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16. Has participation in UNH Cooperative Extension W orkplace Wellness Study impacted how

you feel?
a.
b.
c.
d.
e.
f.
g.
h.

Stayed the same
Improved a little
Improved somewhat
Improved a lot
Worsened a little
Worsened somewhat
Worsened a lot
Choose not to answer
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D. 2 Commitment to Lifestyle Changes and Perceived Barriers to Making Changes
Year 1
Comparison
Questionnaire
Variable

Year 2
Intervention

Baseline

12
Months

Baseline

12
Months

(n = 2 3 )

(n = 18)

(n =23)

Lifestyle
changes willing
to make (n)

1.8 ± 0.2

1.5 ± 0 .2

Barriers to
making
changes (n)

1.5 ±0 .1

1.4 ± 0 .2

Comparison

Intervention

24
Months

12
Months

(n = 19)

12
Months
(n = 18)

(n =19)

(n = 19)

24 Months
(n = 19)

2.0 ± 0 .2

1.7 ± 0.2

1.7 ± 0 .2

1.8 ± 0 .2

2.0 ± 0 .2

2.5 ± 0.2*™

1.5 ±0.1

1.8 ± 0 .2

2.0 ± 0 .3

1.6 ± 0 .3

1.9 ± 0.3

1.9 ± 0 .3

Questionnaire variables in year 1 and year 2. General linear model performed using age and gender as covariates and
post-hoc analyses were conducted using Tukey’s Honestly Significant Difference test. The level of statistical
significance was set at p < 0.05.. Data are presented as LSM ± SE.
* p < 0.05 within group, M p < 0.01 between groups,
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D. 3 Workplace Wellness Exit Survey

1.

A. As a result of participating in the UNHCE Workplace Wellness program: What
lifestyle changes (for example, healthy diet and activity choices, health maintenance
and stress management) have you made? Please be specific.

B. As a result of participating in the UNHCE Workplace Wellness program: What
health changes have you made? Please be specific.

2.

Should UNHCE have a Workplace Wellness Program? Why or why not?

3.

Please comment on the UNHCE Workplace Wellness program (what did you like;
what did you dislike; do you have any suggestions for changes?
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D.4 Exit Survey Responses 2 and 3.

2. Should UNHCE have a Workplace Wellness
Program? Why/Why not?
*» Positive im pact on health
I Positive effect on w ork
environment
I Efficient use o f tim e and
funds
I Needs m ore freq u en t
meetings
I Needs parity for all sites
20

40

60

80

100

I No
P e rc e n t o f G r o u p R e s p o n s e s

3. Comments
*

■ C o m p a ris o n
■ In te r v e n tio n

Unfavorable

Favorable

b e tw e e n g ro u p s

Pearson's Chi square analysis was used to examine category responses between groups. Data are presented as the
percent of all responses within each group. The level of statistical significance was set at p < 0.05.
2. Responses to Exit Question “Should UNHCE have a Workplace Wellness Program". All categories are NS
3. Comments were classified as “Favorable” and “Unfavorable”.
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D.5 Exit Question 2 Responses
Should UNHCE have a W orkplace W ellness Program? W hy o r why not?
Transcribed by J. Allen from Exit responses Fall 2008 of participants in the UNHCE W W
study
1. Yes! It would be great to have som eone to provide wellness program s at
UNHCE. Our schedules are atypical for UNH employees, and having som eone
dedicated to meeting our needs would help to keep staff healthier and more
productive. It is far too easy to push these important topics to the side and let
work dominate. Our crazy schedules and unusual hours can easily lead to bad
eating and exercise habits.
2.

I don't know.

3. Yes-encourage/remind us to make better choices; education about choices is
good-1 learned things from the newsletters.
4.

Nutrition information is very helpful. The tests and measurem ents are good
assessments of your progress or lack of progress in maintaining overall good
health. Knowing that a healthcare professional is interested in your progress
helps you stay focused on good diet and healthy living.

5. Yes! hopefully a motivator for people to try to stay healthier.
6. Yes, increased productivity and decreased stress.
7. Yes- because there are changes I still need to make, despite my good w eight
blood profile etc. This keeps up my awareness.
8. Depends- If they can find a way to be supportive of ah county offices not just
those with teleconferencing sites.
9. Yes, a wellness program would m ake all staff aware of their individual health and
a healthy staff leads to less absence due to health problems that can be avoided
or prevented.
10. Yes, with trying to balance work and fam ily I do not have a lot of free time.
11. Yes- modeling for our own staff and others we work with and it's an investm ent in
our employees health that we will recoup in their performance and stress level.
12. Yes, I think this program brought together a group that was focused on a benefit
for their health. I was not in this group, however did eat lunch with others...I
believe it would be a way of encouraging others to eat well and walk at lunch.
13. Yes, is there if we need it. Accurate info, and good opportunities for participation.
14. yes- good to be updated on blood pressure, cholesterol, glucose (screening).
15. Yes. W e have high stress responsibilities along with high time expectations.
However, along with that needs to be a supervisor w ho also encourages healthy
practices, not one that gives it lip service then adds on more expectations.
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16. yes, focus more on stress m anagement- lack of support from organization.
17. yes- to set the standard fo r health choices/ lifestyle.
18. Yes! Having a workplace focused on em ployee wellness can have a significant
impact on employee health, job satisfaction, & organizational effectiveness.
19. Yes! Most people need assistance sustaining long term wellness initiatives.
20. Yes! Everyone should have to participate in some way- even if its just as little as
walking during a break, it's great to know your em ployer accepts and encourages
healthy steps in your life.
21. Yes! It definitely motivated me to focus on my steps and diet. It was an easy way
to monitor my blood work, etc. It helps to have others in the office working on
being healthy. W e try to serve healthy snacks at meetings, etc. Physical wellness
affects attitudes and motivation and people work harder and sm arter when they
in good health.
22. Yes! I think it has been fun and a morale-booster. Promoting w ellness sends a
positive message of supporting all employees.
23. Yes- wellness improves staff energy & m otivation- better productivity.
2 4 . 1 think a W W P would be helpful as long as it provided sound, practical
information as well as social supports for participants. CE staff spend much of
their day at work and I believe the social support system can be a big incentive
for change.
25. Yes- would be great to have a program. Helpful for ways to com bat day to day
stress in the job!
26. It is a good idea. It would serve to keep people on track and aware of w hat they
need to do to stay healthy or become m ore healthy.
27. Yes. It's easier to make changes to your daily routine when working with a group
of people. In return the organization gets a staff who is healthy and happier. I
would imagine this would equate to improved productivity and less m issed days
of work due to illness.
28. Yes! To help us keep reminders of the w ay we should be taking care of
ourselves.
29. Yes, it gets people to walk and to watch w hat they eat.
30. Yes! It would encourage people-em ployees to continue to make healthier choices
in food and encourage exercise. This would lead to a more positive work
environment and less "sick'' time.
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3 1 .1 think all employers should have wellness program s feeling good about yourself
can translate into feeling good about your job- healthy employees m ake less
medical costs and less sick days.
32. Maybe it has been excellent in som e ways. I have really valued the cholesterol
screening and pedometer. The meetings were not frequent enough and not
terribly valuable, though adm ittedly I didn't attend m any because they took place
during an aerobics class that I teach! The health monitoring w as very valuable
and would be great for UNHCE.
33. Yes, to keep the attention on what keeps us as healthy mindful-action groups.
34. Yes. It would help keep me more aware of my diet & healthy (or bad) habits. By
meeting with others with sim ilar goals it should help me make m ore progress. It is
great to get your dietary habits assessed- 1 x per year would be good (or 2x).
Lunchtim e walking groups would be good.
35. It would be difficult unless all staff were charged to spend a certain am ount of
tim e daily/weekly in wellness related activities. O ff campus sites don't have the
facilities available.
36. This was a great program. By having the pic - tels and newsletters it really helped
to focus on the most important things needed to be addressed for better health.
There is information overload and you don't know w hat way to turn or w hat you
should believe as it is always changing.
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D.6 Exit Question 3. Responses
Please com m ent on the UNHCE W orkplace W ellness program. W hat did you
like; what did you dislike; do you have any suggestions for changes?
Transcribed by J. Allen from Exit responses Fall 2008 of participants in the UNHCE W W
study
1.

1.1 was not in the group that attended the m onthly meetings and I would have
liked to attend- so I disliked that part. 2. I liked the newsletters. They were
interesting and informative. I liked Jorie’s very non-judgmental attitude. 3 . 1liked
the periodic testing. The results were consistent with those done by my doctor
which gave me more confidences that my im provem ent was real.

2.

Great project! Good luck with your PHD. It was all valuable - although for me the
food recall was not so useful. I would have liked my beginning (entry) w eight and
body fat to compare 2 years later. I would have liked more inform ation on the
"peak flow meter" and what it all means.

3.
4.

Hard to say anything since I was part of a control group.

5.

Did not like being in the control group. Did enjoy working with Jorie Allen. She
was terrific and didn't make me feel bad about not losing weight.
6. Great!
7.
8.

Newsletters=excellent I was in control group.
Everything went well, convenient locations for testing so made it easy to do.

9. Jorie was very pleasant and informative. Newsletter well written but not sent often
enough.
10. W orked well for me.
11.1 didn't like the finger prick-1 liked the analyses every 6 months to show w hether I
was balanced/ where I should be or ready to! I liked the newsletter.
1 2 .1didn't receive any newsletters or information- only participated in the testing. Not
sure what happened-1 think there needs to be more confidentiality- though
workplaces make that difficult. Glad to have participated. W ould like a copy of the
final report.
13. I'd like to see more interactive web-based education- such as online quizzes to go
along with a healthy topic and newsletters far in place of the newsletter.
1 4 .1enjoyed being a part of this program. It was great to be able to com bine this
program with my primary care and share the information across the physicians
that I have been working with. I also learned information that benefited my
position and my family.
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1 5 .1 liked trying new food products in the first year. I liked the convenience of the
workplace testing and the pic-tel lunchtime m eetings. Jorie was great to work
with! I can't think of any im provem ents needed. I hope you get good data.
Thanks!
16. Education via video conference worked out well. I appreciate that m uch of the
information went into specific detail. It was good to experience this as a county
staff together.
17. Health assessm ents were great- No personal contact which could have lead to
better outcom es-more changes, one time per month not enough and quarterly did
not seem to have any effect at all for me.
1 8 .1 enjoyed it because I am interested in these topics. I would have liked to see
more variety in & possibly research of the delivery methods that were used fo r the
education delivery. I think it could have been more effective if it had engaged
learners more actively. Thank you so much for the opportunity! I love having the
regular health assessm ents & diet analysis.
1 9 .1 liked the monthly meetings and the information that was given. I didn't like
keeping track of our activity.
20. Programs were diverse and informative. Screenings were helpful with im m ediate
feedback on progress with cholesterol, blood sugar levels, etc. Though difficult
with CE being so spread out, in-person m eetings w ith our county participants
would bring a different dimension to program.
2 1 . 1 loved the meetings. Jorie did an excellent job on sharing inform ation with the
group. I only disliked that som e of my co-workers w ere in the control group so we
weren't able to share in the sam e experiences.
22. Jorie did an excellent job!
2 3 .1 liked the Program- Jorie did a great job. I like seeing how m any steps I could do
and improve my health- by doing steps- walk- at least three tim es a week.
2 4 .1 enjoyed learning about the latest in food nutrition and have tired to incorporate
the information into my diet.
25. Regular checkups a good base line. Didn't like air intake to be. Newsletters were
great. PicTel not a great way to import info.-also lots of technical problem s
26. My suggestions would be to monitor activity (steps) fo r a defined 3-6week period,
PAUSE, then monitor again for a short period 6m onths later. Perhaps it would
defeat the purpose, but I think rewards would be helpful. For exam ple, enter all
the names of those who reputed steps in a drawing fo r fitness stuff, OR the
highest steps wins, OR...I just think these would keep people reporting data.
Another idea would be to issue some kind of challenge to participants- and
reward meeting the challenge. For example eat 6 servings of vegetables daily for
a week, enter the homecoming 5k, do 100,000 steps in 2weeks, etc. I really
enjoyed being part of this and I learned about m yself in the process. Thank you
fo r the opportunity!!
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27. Like the extra kick butt! Most staff in different manner...Eats were very good.
2 8 . 1 did not make most of the lunch meetings, but those I did (or got the presentation
for) were very helpful. The blood work was also very informative.
29. It was an interesting experience. I liked having the info available. It was
m anageable within the current schedule I keep.
3 0 .1 liked the whole program. I liked dedicating the 1 hour to the pictel to focus on
health. It made you be dedicated to the dates we committed to. I liked the topic
focus each session-1 would like to see periodic sessions we could participate in
on pictel. I liked having my screening done on blood weight, etc. I fe lt it helped
give me a personal health profile. Thank you for a great program Jorie. I am glad I
got the chance to participate.
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E. Participant Clinical Report, Instructions and Self-reporting Forms
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E.1 NUTRITION AND HEALTH REPORT DISTRIBUTED TO PARTICIPANTS

Date:

Name:______________________________
County______________________________

Cooperative Extension Workplace Wellness
NUTRITION AND HEALTH REPORT

MY
RESULTS
Weight
Body Mass
Index (BMI)

AREA OF HEALTH RISK

TARGETS
♦

N o rm a l = 1 9 -2 4 .9

♦

O v e r w e ig h t = 2 5 - 2 9 .9

♦

O bese = >30

□

U n d e r w e ig h t

□

O v e r w e ig h t
O bese

BMI Category:
□

Normal

Body Composition
Normal Body Fat %

Percentage Body
Weight

□
□
□
□
♦

Waist
Circumference

M a le : 1 2 -2 0 %
F e m a le : 2 0 -3 0 %
O bese
N o rm a l

M e n - less th a n 4 0

□

In c re a s e d W a is t

inch es

♦

C irc u m f
e re n c e

W o m e n - less th a n 3 5
inch es

Blood Pressure

♦
/

N o rm a l = < 1 2 0 / 8 0

P re -h y p e rte n s io n ( 1 2 0 - 1 3 9 o r
8 0 -8 9 )

T a rg e ts w h e n e le v a te d :
♦

Less th a n 1 4 0 /9 0

♦

W it h d ia b e te s , less th a n

E levated ( 1 4 0 a n d a b o v e o r 9 0
and

1 3 0 /8 0

above)

Blood Pressure Category:
Normal = Less than 120/80

Fasting Blood
Glucose

♦

7 0 - 1 0 0 m g /d l

FBG Category

Total
Cholesterol

Im p a ire d fa s tin g g lu c o s e ( 1 0 0 125)

□

Normal

♦

D e s ira b le = Less th a n
200

Total Cholesterol Category:
□

Desirable
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E levated ( 1 2 6 a n d a b o v e )

□

B o rd e rlin e H ig h = 2 0 0 - 2 3 9

□

High = 2 4 0 a n d h ig h e r

LDL-Cholesterol

♦

O p tim a l = Less th a n 1 0 0

♦

N e a r o p tim a l = 1 0 0 -1 2 9

♦

W it h d ia b e te s o r

u

M e n - L o w = less th a n

I

W o m e n — L o w = less

40

th a n 5 0

c o ro n a ry h e a rt
d is e a s e = less t h a n 1 0 0

LDL - Cholesterol Category:
□ Optimal

Page 2

N a m e ___________________________________________________________ D a te

MY
RESULTS
HDL - Cholesterol

TARGETS

♦

AREA OF HEALTH RISK

O p tim a l = H ig h = 6 0 a n d

□

M en

□

=

W o m e n — L o w = less

T a rg e ts if lo w :
♦

= Low

less th a n 40

h ig h e r

th a n 50

M e n - 4 0 o r h ig h e r a n d
W o m e n - 50 o r h ig h e r

HDL - Cholesterol Category:
□ Optimal
□ Above Risk Level

Triglycerides

♦

N o rm a l = Less th a n 150

□

B o rd e r lin e h ig h = IS O -

□

H ig h = 2 00-499

□

V e r y h ig h = 500 a n d

199

♦ TG Category:
□ Normal

h ig h e r

Diet

□

F ru its a n d v e g e ta b le s : 5 o r m o re
s erving s

L o w c o n s u m p tio n of:
□

F ru its a n d

□

W h o le g ra in

a day

v e g e ta b le s

□

W h o le g ra in b re a d s a n d cereals: 6-11

□

L o w -fa t d a iry : 2-3 serv in g s a d a y

serving s a d a y

b re a d s a n d

Calories:
P ro te in g m

%

C a rb o s g m

%
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c e re a ls
Z

L o w f a t d a ir y

Z

M e a ts and

fo o d s

p ro te in fo o d s

Fat gm

%

A lc o h o l g m
H ig h c o n s u m p tio n of:

%
F ib e r g m

S a tu r a te d f a t
%

O m e g a 6 :O m e g a 3

P:S ra tio

□

T o ta l f a t

□

S a tu r a te d fa t

□

C h o le s te ro l

□

S o d iu m

V ita m in s a n d M in e r a l fa llin g b e lo w th e
RDA:

Physical Activity

□

3 0 - 6 0 m in u te s a d ay o f m o d e r a te

L ow p h y s ic al a c tiv ity

a c tiv ity m o s t if n o t
all d ays

Metabolic Syndrome

♦

L o w risk o f m e ta b o lic s y n d ro m e

□

P o te n tia l ex ists b as e d
on 3 or

□ Indication of metabolic syndrome

m o r e in d ic a to rs :
In c re a s e d
□

W a is t c irc u m fe re n c e

□

B lo o d p re s s u re

□

B lo o d s u g a r

□

T rig ly c e rid e s

L ow
□

10-year Framingham
Coronary Heart
Disease Risk

□

Less than 10% risk
%

HDL

□

1 0 -2 0 %

□

G re a te r

risk

risk

th a n
20%
risk
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Lipid Profile and Blood Glucose Test Explanations
A Lipid Profile is a detailed measure of the fats in your blood. It consists of measuring your total
cholesterol, HDL cholesterol, and triglycerides and calculating your LDL cholesterol. NCEP
(National Cholesterol Education Program—a study by a panel of experts) ATP III Guidelines
recommend a complete lipid profile as the initial test and testing every 6 weeks until lipid goals
are met and every 4 -6 months thereafter.
The "bad" cholesterol is called Low Density Lipoprotein (LDL) cholesterol. It contributes to the
buildup of fat deposits in your arteries (atherosclerosis), which can cause decreased blood flow
and heart attack.
About 65% o f the cholesterol in your blood is LDL An LDL of less than 130 mg/dL is
desirable. If you have a personal history o f coronary heart disease or diabetes, or if you
have multiple risk factors, your LDL should be below 100 mg/dL.

Cholesterol is one of several components that form your lipid profile. Total Cholesterol (TC) is a
measure of the total amount of both "good" and "bad" cholesterol in your blood at a given time.
TC is measured in milligrams per deciliter (mg/dL). A TC o f less than 200 mg/dL is desirable.

The "good" cholesterol is called High Density Lipoprotein (HDL) cholesterol. It removes excess
cholesterol from your arteries and moves it to the liver for further processing or to be
eliminated from the body.
The higher your HDL, the better. An HDL o f 60 mg/dL or higher is beneficial and
considered a negative risk factor. An HDL o f 40 mg/dL or lower is considered a risk
facto r fo r heart disease. A TC/HDL Ratio is total cholesterol divided by HDL cholesterol. Some
healthcare professionals may use this ratio to assess risk fo r developing heart disease—lower
ratios are associated with lower risk.

Glucose (GLU) is a measure of the sugar level in your blood. Fasting glucose levels should be
below 100 mg/dL. If you are overweight or have a family history of diabetes, your glucose levels
should be checked periodically to see if you have diabetes.

Triglycerides (TRG) are composed of fatty acids and glycerol. Like cholesterol, they circulate in
your blood, but are stored in body fat and used when the body needs extra energy. While your
triglyceride level can be significantly affected by how recently you've eaten, total cholesterol
and HDL are only slightly affected.
After eating, your triglyceride level increases significantly. If your body processes the fa t
efficiently, the level o f triglycerides will decrease naturally. Your fasting triglyceride level should
be below 150 mg/dL.

Your healthcare professional will carefully examine the test results of your lipid profile to fully
assess your risk for coronary heart disease.

S o urce: C h o le s te c h C o rp o ra tio n 2 0 0 5 w w w .c h o le s te c h .c o m
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E.2 SOURCES FOR CLINICAL TE ST VALUE GUIDELINES

Measures

Source

W eight
Body Mass Index

Clinical Guidelines on the Identification, Evaluation, and
Treatment of O verweight and Obesity in Adults: The
Evidence Report (1)

Percentage Fat Mass

Guidelines from the Am erican Council of Exercise (2)

W aist Circumference
Blood Pressure
Fasting Blood Glucose
Total Cholesterol
LDL-Cholesterol
HDL- Cholesterol
T riglycerides
Metabolic Syndrome

National Cholesterol Education Program Expert Panel on
Detection, Evaluation, and Treatment of High Blood
Cholesterol in Adults (Adult Treatment Panel III) (3)

Diet
Physical Activity

1.

2.
3.

4.

U. S. Department of Agriculture and U. S. Departm ent of
Health and Human Services 2005 Dietary G uidelines for
Americans, Dietary Reference Intakes (DRI) and
Recommended Dietary Allowances (RDA)(4)

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and
Obesity in Adults: The Evidence Report. . In: National Heart LaBI, ed. NIH Publication
No. 98 - 4083 ed: National Institutes of Health, 1998.
Muth ND. American Council on Exercise(ACE) Guidelines for body fat percentage.
American Council on Exercise, 2006.
Executive Summary of The Third Report of The National Cholesterol Education Program
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E.3 INSTRUCTIONS FOR DIET RECORD
H O W TO RECORD YOUR DAILY FOOD INTAKE

1.

Record everything you eat or drink. Use a new diet intake sheet for each day; Indicate the
name of the MEAL or the TIME of the snack, WHERE the food is provided or prepared
(cafeteria, at home, vending machine, etc.), the FOOD ITEM, the AMOUNT eaten, and briefly
describe how it was prepared (fried, boiled, broiled, etc). If the item was a brand name
product, include the name.

2.

Try to eat what you normally eat and record everything. This dietary survey will only be
useful if you give an accurate account of what you eat.

3.

List amounts in common household units that you are familiar with (e.g. teaspoons, cup, pat,
ounce, inch, etc.).

4.

MILK. - incidate whether milk is whole, low fat (1 % or 2%), or skim. Include flavoring if one
is used.

5.

VEGETABLES AND FRUITS - one average serving of cooked or canned fruits and vegetables is
about a half cup. Fresh whole fruits and vegetables should be listed as small, medium or
large. Be sure to indicate if sugar or syrup is added to fruit and list if any margarine, butter,
cheese sauce or cream sauce are added to vegetables. When recording salad, list items
comprising salad and be sure to include salad dressing used.

6.

EGGS - indicate method of preparation (scrambled, fried, poached, etc.) and the number
eaten.

7.

MEAT - POULTRY -FISH - indicate approximate size (e.g. 2 inch by 2 inch by 1 inch) or
weight in ounces of the serving. Be sure to include gravy, sauce or breading added.

8.

CHEESE - indicate kind, number of ounces, cubic inches, or slices and whether it is made
from whole milk, part skim or is low calorie.

9.

CEREAL - specify kind, whether cooked or dry and measured or estimated in terms of cups
or ounces.

10. BREAD and ROLLS - specify kind (whole wheat, enriched white, rye, etc.), number and
thickness of slices or size in inches. Remember to include in your description any butter or
margarine used on bread.

11. BEVERAGES - include every item you drink including water. Be sure to record cream and
sugar used in tea and coffee, whether juices are sweetened or unsweetened and whether soft
drinks are diet or regular.

12. FATS - remember to record all the butter, margarine, oil and any other fats used in cooking
or on food.
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13. VITAMINS and/or MINERAL SUPPLEMENTS - indicate type and quantity consumed and
amount of nutrients provided.

14. MEDICATIONS - indicate name and prescribed dosage.
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PORTION GUIDE

SEVEN WAYS TO SIZE UP YOUR SERVINGS
M e a s u re fo o d
W h e n

1

p o r t io n s s o y o u k n o w

e x a c tly h o w

m u c h f o o d y o u 'r e e a t in g

a f o o d s c a le o r m e a s u r in g c u p s a r e n 't h a n d y , y o u

can

s t ill e s t im a t e y o u r p o r tio n

R e m e m b e r

3 o u n c e s o f m e a t is a b o u t t h e s i z e
a n d t h ic k n e s s o f a d e c k o f p la y in g
c a rd s o r a n a u d io ta p e c a s s e tte .

. A

m e d iu m

p ea ch

a p p le o r

is a b o u t t h e s iz e

o f a te n n is b a ll

U

• •

o z o f c h e e s e is a b o u t

m

• • H
• • i
• • i

t h e s iz e o f 4 s ta c k e d d ic e

• *'
•

lh

c u p o f ic e c r e a m

is a b o u t t h e s iz e o f a
r a c q u e t b a l! o r te n n is b a ll

1 I c u p o f m a sh ed

p o ta to e s o r

b r o c c o li is a b o u t t h e s i z e o f
y o u r f is t

11 te a s p o o n o f b u tte r o r
p e a n u t b u t t e r is a b o u t t h e
s iz e o f t h e t ip o f y o u r th u m b

I o u n c e o f n u ts o r

fl® S o

s m a ll c a n d ie s e q u a ls
o n e h a n d fu l

M O S T IM P O R TA N T
Especially if you're cutting
cafcries. remember to keep
your <4et nut ntious

0

2-4 servings from the
M ilk Group for calcium

V-5 servings from the
Vegetable Group for vitam in A
2-4 servings from the
Fruit Group for vitam in C

12 -3 se fvtr^s from the
'
M eal Group for iron

o
H *m

*L O f t m O O U N O C fta i i » a

i
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6-11 sen/ngs from the
Grain Group for fiber

FOOD RECORD SHEET

f /f lm £ : -----------------;— ------------------D ata:
H o a l <*
T in a ,

K bara
E sta n

ta o u n t

Food ite m

Hew
F rtp a ra d

COda

. A n xxin t

■

•

;

•

c
'N

1

i
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E. 4 PEAK FLOW REPORTING FORM
Essentials fo r getting q u ality m easurem ents

•
•
•
•

You MUST breathe in as deeply as possible; this is critical for a reproducible
measurement.
Put the mouth piece in your mouth and seal your lips, do not just press the
mouthpiece up against you lips.
Wait for at least 30 seconds between tests
M ea su re vou r Peak Flow Rate close to th e sam e tim e each d a v . One suggestion is
to measure between 7and 9 a.m. and between 6 and 8 p.m.

A "normal" Peak Flow Rate is based on a person's age, height, sex and race. A standardized
"normal" may be obtained from a chart comparing the patient with a population without
breathing problems. Therefore, it is important for you and your doctor to discuss what is
considered "normal" for you. 2006 American Lung Association®.
Instructions for performing a Peak Flow Rate Test are on the back side of this chart. Please do
the test twice daily for a week, following these instructions. When the week is over, please mail
the chart in the self-addressed stamped envelope provided. IMPORTANT: Don't throw your peak
flow meter away. We will use it for repeat tests.

Name or ID

i
Peak Expiratory Flow Rate

Date
Liters/min

am

pm

am

pm

am

pm

am

pm

am

pm

am

pm

am

pm

am

pm

Forced Expiratory Volume in one second (FEVi)
Date
am

pm

am

pm

am

pm

am

Liters

\
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pm

am

pm

am

pm

PROCEDURE FOR USING KOKO PRO 6 PEAK FLOW METER.
•
•
•
•

•
•
•

hold the meter away from the mouth (making sure the vents are not covered) and
breathe in as DEEPLY as possible
press the blue button on the device, and wait for the second beep
seal your lips around the mouthpiece
blast air out as fast and as far as you can, until the lungs are absolutely empty
in a few seconds the PEF and FEV1 readings will be displayed
repeat the measurement 3-times and record the highest test value
only record PEF and FEV1. The lower display will alternate values, be sure it is FEV1
that you record

The Display

Y o j i PEF as

c c m o a re d to

average

Value for.

FEVl

PEF - Peak Expiratory Flow ra te

PEF is the highest rate of flow that you can exhale. It can occur at any time during your
exhalation. PEF is a measure of the respiratory system's ability to clear air from the lungs. PEF
depends on your body size, sex, race, gender and age. PEF is measured in liters per minute.
FEVi - Forced Expiratory V o lu m e in th e first second

FEVj is the volume of air that you exhaled during the first second. Measured in liters.
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E.5 Steps per minute for alternative activities
Source: UNH Center for Health Enhancement
These exercise equivalents were developed so participants who enjoy activities in
addition to walking can log credit for those different activities. These are estimates. 2000
steps measured with a pedometer = 1 mile.

Aerobics, high impact

203

Golfing with a cart

101

Aerobics, low impact

145

Grocery shopping

67

Aerobics, step

246

Handball

348

Badminton, casual

131

Hiking, 10 - 20 lb load

217

Badminton, competitive

203

Hiking, 21 - 42 lb load

232

Basketball, game

230

Orienteering

260

Basketball, recreational

174

Painting

131

Bicycling, leisurely

116

Pilates

101

Bicycling, stationary

203

Ping Pong

116

Bowling

87

Racquetball, casual

203

Boxing

348

Racquetball, competitive

290

Canoeing, light

87

Raking leaves

125

Chopping wood, around home

174

Roller skating

203

Circuit training

232

Rowing, light

101

Cross-country skiing, intense

260

Rowing, moderate

203

Cross-country skiing, moderate

232

Running, 10 mph (6 min/mile)

463

Cross-country skiing, slow

203

Running, 8 mph (7.5 m in /m ile)

391

Dancing

131

Running, 6 m ph (10 min/mile)

290

Downhill skiing

174

Running, 5 m ph (12 m in/ mile)

232

Elliptical trainer

203

Scuba diving

203

Firewood, carrying

145

Snow shoveling

174

Firewood, sawing with handsaw

217

Snowboarding, light

150

Firewood, stacking

145

Snowboarding, moderate

182

Football

260

Soccer, recreational

203

Gardening, light

116

Soccer, competitive

290

Gardening, heavy

174

Softball

145

129

Gardening, weeding

131

Squash

348

Golfing, without cart

131

Stair climbing, machine

260

Stair climbing moderate

334

Jumping rope, fast

348

Stair climbing, slow

232

Jumping rope, moderate

290

Stair climbing, vigorous

434

Karate

290

Stretching

72

Kickboxing

290

Swimming, backstroke

203

Mowing

160

Swimming, breaststroke

290

Tae Kwon Do

290

Swimming, butterfly

319

Tai Chi

116

Swimming, freestyle

203

Tennis, doubles

174

Swimming, leisure

174

Tennis, singles

232

Swimming, treading water

116

Trampoline

101

Hiking, general

172

Volleyball, game

232

Horseback riding

116

Volleyball, leisure

87

Horseback riding, trotting

188

W ash the car

87

Housework, light

72

W ater aerobics

116

Housework, mopping floors

101

W ater skiing

174

Housework, scrubbing the floor

110

W ax the car

131

Housework, vacuuming

101

W eight lifting, moderate

87

Housework, washing windows

87

W eight lifting, vigorous

174

Ice skating

203

Yard work

145

Judo

290

Yoga

72
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